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AAE : Annurca apple extract 
AFA : Apple fruit cv Annurca 
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Abstract 
The present thesis work aimed to the in vitro and in vivo evaluation of the nutraceutical 
potential of whole fruit or only of its polyphenolic fraction mainly obtained from a specific 
apple Malus pumila Miller cv Annurca. This apple fruit is used in various manners, the 
whole fruit is enabled to produce a functional food, while the polyphenolic extract is used 
to design and project different nutraceutical formulations and vegetal extract innovative 
using as potential medical device. Various healthy human bioactivities of Annurca apple 
formulations have been investigated, from the cholesterol lowering-effect, atherosclerosis 
prevention to anticancer activity. Particularly, the whole fruit Annurca apple is used to the 
preparation of probiotic apple puree, a probiotic juice, with various purposes: no dairy 
probiotic product, with higher bioaccessibility (percentage increases of 40.12% of TC, and 
of 11.89%of antioxidant activity) and consequently higher bioavailability of phenolic 
compounds than in simple puree. Additionally preliminary in vivo study, has shown a 
reduction of TMAO blood levels (63,12%), due to the combination effects of probiotic and 
Annurca apple polyphenols daily intake. Industrial scale-up of row lab scale polyphenolic 
Annurca apple extract, resulting in two products AMS (polyphenolic extract 
microencapsulated with maltodextrins (400mg)) and AMSbz (polyphenolic extract 
microencapsulated with maltodextrins (400 mg), biotin (0.20 mg), selenomethionine (80.0 
µg), and zinc acetate (21.0 mg)). From randomized clinical trial, was obtained on average, 
after two months of treatment a % increase of hairs growth, weight and keratin content by 
118.3, 37.3, and 35.7%. After, in vitro treatment of HaCaT cells (human keratinocyte cell 
line) increased the keratin expression of three fold against the control. These effects were 
ascribable a dimeric procyanidin. The same compound is responsible of interaction at 
duodenal level, with intestinal micelle, particulary interacting with phosphatidylcholine 
determine a breakage micellar system, causing the cholesterol precipitation, limiting its 
intestinal absorption. Finally, lab and industrial scale of polyphenolic Annurca apple 
extracts were tested on in vitro cultures of cells carrying FAP (Familial Adenomatous 
Polyposis) mutations and on ex vivo biopsies of FAP patients, the WNT inhibitory activity 
of Annurca was studied. Duodenal digested apple extract has showed no inhibitory activity 
on WNT pathway, the signaling via responsible of FAP, but stronger inhibitory activity has 
been shown by industrial scale product, based on another apple cultivar named 
“Limoncella” Malus Domestica cv Limoncella. This effect was ascribable to the quercetin 
content of Limoncella’s industrial product higher than the equivalent Annurca version. 
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Research Objectives 
The evidence that the regular consumption of apples leads to beneficial health effects, 
ranging from a reduction of CVD (cardiovascular disease) risk to anticancer prevention, 
encouraged me to explore and deepen the nutraceutical potential of the “Annurca” apple 
whole fruit or only its polyphenolic extract, by both in vitro and in vivo studies. 
Annurca apple polyphenolic extract’s bioactivities explored were :  
 promoting hair growth, both in vitro and in humans; 
 lowering the cholesterol solubility in an in vitro model of duodenal bile micellar 
solution; 
 WNT inhibitory activity in vitro and on ex-vivo biopsies (inhibitors of WNT/β 
catenin pathway have been shown to efficiently act as chemopreventive agents for 
patients affected by Familial Adenomatous Polyposis (FAP)). 
Functional food based on Annurca apple whole fruit shows the following bioactivites : 
 Increase polyphenolic bioaccessibility in vitro; 
 Decrease of TMAO (cardiovascular risk marcker) blood levels in vivo. 
Date and proven the previous biological activities, aim of the present thesis work is to 
formulate nutraceuticals or functional foods that will find application in disease prevention. 
Today, the nutraceutical product, whitch its formulation and activity, were described in this 
thesis work is available in Italian commerce with the name of : AppleMets hair
TM
. 
 
 
. 
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Introduction 
Hippocrates said, “Let food be thy medicine, and medicine be thy food”. It was the 377 
a.c., when Hippocrates with this sentence underlined the ancient concept of the importance 
of food for health. The human evolution goes with the food evolution, and the food 
products and manufacturing changes relating to the human needs. “An apple a day keeps 
the doctor away”, these is a folk saying most famous. Today it is known that all the 
beneficial healthy effects associated to the apple consumption are ascribable, not an 
“unknown” and “mysterious” compounds, but largely to their characteristic polyphenolic 
complex (Knekt et al., 1996; 2000; 2002; Aprikian et al., 2001). Particularly, in the present 
thesis work, my attention has been addressed on an apple cultivar typical of south Italy: 
Malus pumila Miller named “Annurca”, which is listed as a PGI product and is known as 
“Mela Annurca Campana IGP” product from the European Council [Commission 
Regulation (EC) No. 417/2006)]. This apple has been already shown to possess 
nutraceutical potential in virtue of its ability to reduce cellular glucose levels and lipid 
uptake (Tenore et al. 2013,2014,2016 and Sommella et al. 2015). The whole fruit or only 
the polyphenolic content of this apple cultivars are formulated and elaborated in various 
ways to evaluate and test new different bioactive activities both in vitro and in vivo 
systems. The formulations and applications prepared were the following : 
 Nutraceuticals 
 Functional foods 
 Medical device  
 In 1989 Stephen De Felice, coined the term “nutraceutical” the union of the terms 
“nutrition” and “pharmaceutical”, he was the founder and chairman of the Foundation for 
Innovation in Medicine (FIM), Cranford, NJ in 1989. A nutraceutical can be defined as “a 
food or a part of a food that provides medical or health benefits, including the prevention 
and/or the treatment of a disease” (Kalra et al., 2003). Nutraceutical formulations have a 
potential to deliver in concentrated form, the presumed food bioactive agents , presented in 
a non-food matrix and used with the purpose of enhancing health in dosages that exceed 
those that could be obtained from normal foods (Zeisel, 1999), they look like a drug and 
are generally sold in form of : pills, capsules, tablets etc. (Gul et al.,2016). 
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Functional foods are food and food derivatives that provide beneficial health effects in 
addition to their basic nutritional properties (Menrad 2003). It should be a food similar in 
appearance to a conventional food (beverage, food matrix), consumed as part of a usual 
diet, contains biologically active components with demonstrated physiological benefits, 
and offers the potential of reducing the risk of chronic diseases beyond basic nutritional 
functions (Food and Agricultural Organization of the United Nations (FAO), 2007). 
Functional foods are often enriched or fortified with bioactive substances through a process 
called nutrification, examples should be food products that contain specific minerals, 
vitamins, fatty acids, or dietary fiber, foods with addition of biologically active substances 
such as phytochemicals or other antioxidants and probiotics. The possible categories of 
functional foods products are shown in the following table (Gul et al., 2016). 
 
         Category           Definition                   Examples  
Basic Food Food or food product that 
naturally contains bioactive 
compounds 
 Carrots naturally contains 
Beta-carotene 
 
Processed Foods with 
added bioactives 
 
Bioactive agent is added to 
the food during the processing 
 Orange juice added with 
calcium 
 Yogurt with increased level 
of probiotic 
 Fermented Juice 
Foods enhanced to 
have more of 
bioactive 
Normally Bioactive’s level is 
modified or concentrated  
 Tomatoes with increased 
lycopene content 
 Eggs with increased levels 
of omega-3 fatty acid 
 
Table 1 : Categories of functional foods (Gul et al., 2016). 
 
 
Directive 2007/47/EC defines a medical device as : any instrument, apparatus, appliance, 
software, material or other article, whether used alone or in combination, together with any 
accessories, including the software intended by its manufacturer to be used specifically for 
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diagnostic and/or therapeutic purposes and necessary for its proper application, intended by 
the manufacturer to be used for human beings for the purpose of: 
 Diagnosis, prevention, monitoring, treatment, or alleviation of disease; 
 Diagnosis, monitoring, treatment, alleviation of, or compensation for an injury or 
handicap; 
 Investigation, replacement, or modification of the anatomy or of a physiological 
process; 
 Control of conception. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1 : Graphical illustration of different formulations of Annurca Apple whole fruit or of its    
polyphenolic extract  
 
 
 
Nutraceuticals Medical device 
Functional Food  
Polyphenolic extract 
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Annurca apple, the queen of the apples. An overview of  history, origin and 
cultivation 
 
“Mela Annurca Campana IGP” is a precious apple cultivar (Malus pumila Miller), typical 
of Campania region. It is defined the ‘queen of the apples’ thanks to its marked 
organoleptic qualities: flavor, taste and scent. This apple is famous for its white compact 
and crisp flesh, agreeably slightly sour and perfume. 
Its description in the paintings found in the excavations of Ercolano and its documentation 
in “Naturalis Historia” by Pliny the Elder testifies its very ancient relationship with the 
Campania Felix. It is present in this geographical area for at least two millennia, 
particularly the precise origin area seems to be the area near Pozzuoli. This information, is 
confirmed by the most ancient name attributed to this apple cultivar by Pilinys the Elder, “ 
Mala Oracula”, because of its production in proximity to Averno Lake (situated in the 
Pozzuoli region), which, according to the ancients, was the location of the underworld, so 
it was produced near the Orcus. In the time this denomination changed in anorcola, 
annorcola, until the 1987, when Giuseppe Antonio Pasquale in his opera “ Manuale de 
Abrocoltura” named this cultivar “Annurca”. Today, this product is listed as a PGI product 
and is known as “Mela Annurca Campana IGP” product from the European Council 
[Commission Regulation (EC) No. 417/2006)]. 
PGI is the acronym of Protected Geographical Indication. According to the Regulation 
(EC) No. 510/2006, “it is the name of an area, a specific place or, in exceptional cases, the 
name of a country, used as a description of an agricultural product or a foodstuff, 
 which comes from such an area, place or country; 
 which has a specific quality, goodwill or other characteristic property, attributable 
to its geographical origin; 
 at least one of the stages of production, processing or preparation takes place in the 
area.” 
Thus, in order to receive the PGI recognition, the entire product must be traditionally and 
at least partially manufactured (prepared, processed or produced) within the specific 
region, thus its production is possible only in 137 municipalities of Campania region. The 
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strong disciplinary, explain the particular and unique cultivation, harvasted and ripening 
methods. According to these guidelines, the harvesting takes place in mid-September and it 
is made by hand. After the collection, apples are subjected to the reddening on the ground 
in the so-called “melai”, which are small plots of land, not larger than 1.50 meters. “Melai” 
are covered by soft material layers, such as hemp, pine needles, wood shavings or other 
plant materials and they are arranged in order to avoid water stagnation and to be protected 
from the sun. During their permanence there, apple fruits are arranged in rows; they are 
sprayed daily with water and cannot receive any plant health treatment. When a part of the 
surface of the fruit becomes red, the apples are turned to allow the reddening on the 
opposite side. The minimum dimensions required are 60 mm in diameter and 100 g in 
weight. The shape is flattened and roundish and there is a short and weak stalk. 
 
 
Fig 2 : Melannurca Campana IGP 
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Polyphenols 
Eating five servings of fruits and vegetables per day! This is what is highly recommended 
and heavily advertised nowadays to the general public to stay fit and healthy! Drinking 
green tea on a regular basis, eating chocolate from time to time, as well as savoring a 
couple of glasses of red wine per day have been claimed to increase life expectancy even 
further! Why? The answer is in fact still under scientific scrutiny, but a particular class of 
compounds naturally occurring in fruits and vegetables is considered to be crucial for the 
expression of such human health benefits: the polyphenols! Polyphenols constitute one of 
the most numerous and ubiquitous groups of plant metabolites and are an integral part of 
both human and animal diets. Ranging from simple phenolic molecules to highly 
polymerized compounds with molecular weights  greater than 30,000 Da (Quideau et al., 
2011). In the following paragraphs will be illustrated the chemical classification, and 
several polyphenols bio-features such as healthy biological activities, bioaccessibility and 
bioavailability. 
Classification 
From chemical structure point of view the polyphenols can be divided in two classes, 
related with the number of cycle rings and the type of functional group. Practically, the 
most used classification is the distinction in flavonoids and not flavonoids compounds 
(Cheynier, 2005). 
Flavonoids 
The term flavonoids is a collective noun for plant pigments, mostly derived from benzo--
pyrone. They consist of two phenolic rings, named A and B, that are linked together by 
three carbon atoms, forming an oxygenated heterocyclic ring, named C.  In base on the 
saturation level, C-ring substitution pattern and opening of the central pyran ring they are 
classified in (Middleton et al., 2000): 
 Flavonols; 
 flavones; 
 flavanones; 
 isoflavones; 
 anthocyanidins; 
 flavanols (or flavan-3-ols). 
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Flavonols present a double bond between C2 and C3, a ketonic function in C4 position and 
a hydroxyl group at the C3 position (De la Rosa et al., 2010). They are present in food in 
free or glycosylate form and the sugar portion could be : glucose, rhamnose, galactose, 
arabinose, xylose and glucuronic acid. The most diffuse aglycone compounds are the 
Quercetin, Kampherol and Myricetin. These compounds are typically present in the red 
wine and are particularly interesting in terms of their effects on human health, 
predominantly because of their role as antioxidants, although the precise mechanism of the 
oxidation process is not entirely understood. However, it is known that their activity 
depends from their structure and in particular the substitution with a 4-keto and 3- or 5-
hydroxy group is considered essential for the metal ion chelation function. This ability to 
complex ion contributes to their antioxidant properties, to prevent the formation of free 
radicals. The presence of these compounds in the wine differs from that present in the 
grapes must due to the presence of aglycone forms, which are the result of hydrolysis of 
the glycosylated form during vinification, maturation and aging of wine. Other vegetable 
sources are: onions, curly kale, leeks, broccoli, blueberries. (Manach et al., 2004). 
Flavones have a double bond between C2 and C3 and a ketone group at the C4 position 
(de la Rosa et al., 2010). They are present largely in the mandarin skin and its content is up 
to 6.5 g/L of essential oil of mandarin (D’Archivio et al., 2007). 
Flavan-3-ols or flavanols are found in the solid part of grapes (peels, seeds and stems) in 
monomeric or polymeric forms. The basic units of these compounds are four monomers: 
catechin, epicatechin, gallate and epigallocatechin. The first two are ortho-hydroxylated at 
position 3 'and 4' of ring B while the remaining ones have a further 5 'substitution; then it is 
possible to replace with gallic acid leading to esterification. The asymmetricity of positions 
2 and 3 causes the  flavanols’s split into two classes of diastereoisomers. These base units 
are generally organized to form a polymers, the main representatives are 
proanthocyanidins, named also condensed tannins, when the constituent units ranging from 
2 to 11 base units (D’Archivio et al., 2007). These compounds are very abundant in tea and 
fruit, grapes and chocolate and are responsible of astringent character of fruit (grapes, 
apples, berries, etc.) and beverages (wine, cider, tea, beer etc) and for the bitterness of 
chocolate (Rasmusen et al., 2005).  
Flavanones are also named dihydroflavones. In these molecules, the ring C is saturated 
and presents an oxygen atom at the C4 position (De la Rosa et al., 2010). The main sources 
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in human foods are tomatoes and some aromatic plants, such as mint, but the richest are 
citrus fruits. These compounds appear generally glycosylated by a disaccharide at position 
7. The main aglycones are naringenin (present in grapefruit), hesperetin (found in orange) 
and eriodictyol (found in lemon) (Manach et al., 2004). 
Isoflavones have B and C rings linked through C3 position, instead of C2 position, 
peculiar of the other kinds of flavonoids (de la Rosa et al., 2010). They are found almost 
exclusively in leguminous plants, both as glycosides and aglycones. The most important 
sources in human diet are represented by soy and soybean-derived products. Genistein, 
Daidzein and Glycitein are the most important compounds that belong to this class 
(Manach et al., 2004) 
Anthocyanidins are colored molecules responsible of red/ purple color of fruit, flower and 
vegetables. In vegetables they are present in aglycone form and in glycosylate called 
antocyanidins (D’Archivio et al., 2007).The glycosidation most frequent is characterized 
by the sugar moiety mainly attached at the 3-position on the C-ring or at the 5, 7-position 
on the A-ring, while the substitution in 3’-, 4’-, 5’-position on the B-ring is very rare 
(Mazza et al., 1993). Food contents are generally proportional to itself color intensity, they 
are present largely in: peels apple, blackcurrants, blackberries, cabbage, beans, onions, 
radishes (D’Archivio et al., 2007). 
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Fig. 3: General chemical structure of flavonoids and their different classes (Ravishankar et. al 
2013) 
   
 
Not flavonoid compounds 
Not-flavonoid compounds are characterised by heterogeneous chemical structures and are 
classified into three groups: phenolic acids, lignans and stilbenes (Cheynier, 2005).  
Phenolic acids can be distinguished in two classes: derivatives of benzoic acid and 
derivatives of cinnamic acid (D’Archivio et al., 2007). The major sources of benzoic acid 
are red fruits, black radish, onions and tea. However their concentrations in edible plants 
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and fruit are very low, several mg/Kg of fresh weight (FW), exception for the gallic acid 
which is present in the concentration of 4g/ kg (FW) of tea (Barberan et al., 2000). These 
compounds are often arranged with other molecules, to form very complex structures such 
as hydrolysable tannins (gallotannins in mangoes and ellagitannins in red fruit such as 
strawberries, raspberries, and blackberries) (Clifford et al. 2000). Hydroxybenzoic acids, 
both free and esterified, are found in only a few plants eaten by humans, thus they have not 
been extensively studied and are not currently considered to be of great nutritional interest. 
The most important are protocatechuic acid and gallic acid. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: Hydroxybenzoic acid structure and its possible derivatives. 
 
 
Hydroxycinnamic acids are more common than hydroxybenzoic acids and consist mainly 
of p-coumaric acid, caffeic acid, ferulic acid and sinapic acid. Their content in edible plant 
is very low excepted for blackberries which contain up to 270 mg/kg fresh (Shaidi et al., 
1995).It’s very difficult to find these compounds in free form in the edible plant and fruit , 
because they are present mostly in the glycosylated and esters derivatives of quinic acid, 
shikimic acid and tartaric acid  (Manach et al., 2004). The most abundant in the fruits is the 
 
R1                 R2               R3 
p-Hydroxybenzoic acid            H                   H                 OH    
Protocatechuic acid                  OH                H                 OH          
Gallic acid                                OH                OH              OH        
Vanillic acid                           OCH3             H                 OH  
Syringic acid                          OCH3            OCH3           OH  
Methyl p-hydroxybenzoate       H                   H               OCH3    
Mhetyl gallate                           OH               OH             OCH3 
Ethyl protocatechuate               OH                 H           OCH2CH3                   
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caffeic acid, which represents the 75% of the total hydroxycinnamic acid in the fruits, both 
in the free and glycosylated form. The most studied for nutraceutical purpose is the 
chlorogenic acid, a combination of quinic and caffeic acid. Chlorogenic acid is largely 
studied for his ipoglycemic activity, it is very abundant in the coffe. A  single cup of coffe 
may contain a 70-350 mg of chlorogenic acid for cup, it is established the maximum intake 
of chlorogenic acid by drinking coffe is 0.5-1.0 g daily (Jhonston et al., 2003; Clifford 
2000 and Olthof et al., 2000). 
 
 
 
 
 
 
 
 
 
Fig. 5: Hydroxycinnamic acid and his major derivates. 
Lignans are formed of 2 phenylpropane units (Figure 6). They are present in very low 
concentration in grains, fruit, cereal and especially in the linseed (up to 3.7 g/kg dry wt) 
where they have a concentration of 1000 times more high than in other food sources. 
 
 
 
 
 
Fig. 6: Lignan structure. 
 
                                    
                                    R2 = OH : p-Coumaric Acid 
                                    R2 = R3 = OH Caffeic Acid 
                                    R3 = OCH3, R2 = OH : Ferulic Acid 
                                    R1 = OCH3, R2 = OH, R3 = OCH3 : Sinapic Acid 
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Stilbenes, finally, are hydrocarbons consisting of ethene substituted with a phenyl group 
on both carbon atoms involved in the double bond. The most important exponent is 
resveratrol, which is contained chiefly in red wine (Manach et al., 2004) and particularly in 
fresh skin of red grapes reach a concentration of : 50-100 g/kg net weight (Baliga et al., 
2005). (Figure 7). 
 
 
 
 
 
 
Fig. 7: Stilbenes structure. 
 
Human biological activity 
Several epidemiological studies and associated meta-analysis reported that polyphenols or 
polyphenols-rich diet may play a significant role in health, since they can protect against 
the development and progression of some pathologies that are associated with oxidative 
stress, such as cancer, cardiovascular and neurodegenerative diseases, diabetes and 
osteoporosis (Graf et al., 2005; Arts et al., 2005). Polyphenols, in fact, are strong 
antioxidant and  they can act both as chain breakers and as radical scavengers (Rice-Evans, 
2001), thanks to the fact that the phenolic groups can accept an electron and form stable 
phenoxyl radicals. Thus, by virtue of their antioxidant properties, they may protect cell 
constituents from oxidative damage and reduce the risk of onset of various degenerative 
diseases associated to oxidative stress such as Alzheimer's and Parkinson’s diseases (Dai et 
al., 2006; Aquilano et al., 2008; Pandey et al., 2009). The chemopreventive effects of 
polyphenols are due to several mechanisms of action, such as antioxidant and anti-
inflammatory activities, inhibition of proliferation, induction of cell cycle arrest, induction 
of apoptosis, induction of cytochrome P450 enzymes and changes in cellular signaling 
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(Yang et al., 2000; García-Lafuente et al., 2009). Additionally, they play a strong role in 
the prevention of metabolic syndrome .They are able to inhibit the production of LDL 
oxide, the major responsible of the develop of atherosclerosis process (Aviram et al., 
2000), determine the increase of HDL and improving endothelial functions (García-
Lafuente et al., 2009). Polyphenols, in particular ,found application also in the diabetic 
pathologies, they inhibit the amylase, -glucosidase and glucose intestinal absorption 
(Iwai et al., 2004 and Tadera et al., 2006). One of the most important property of 
polyphenols recently identified is their preventive effect against long-term diabetes 
complications including retinopathy, nephropathy and neuropathy. For example, 
anthocyanins facilitate blood flow and prevent diabetes-induced microangiopathy, increase 
microvascular permeability, decrease leucocytes aggregation in vascular cell wall and 
improve capillary filtration of albumin (Ghosh et al., 2007; Rhee et al., 2002). 
Polyphenolic compounds, also, have wonderful modulatory effects on many aspects of 
metabolic, endocrine and cellular signaling transduction of adipose tissue. Some 
polyphenols such as catechins increase β-oxidation in adipocytes, down-regulate the 
enzymes and genes involved in lipogenesis and fatty and up-regulate lipolysis pathways 
via induction of hormone sensitive lipase (Nakazato et al.,2006; Osada et al., 2006). Some 
polyphenols, including green tea catechins and epicatechins, chlorogenic acid, ferulic 
acids, caffeic and tannic acids, quercetin and naringenin, could interact with absorption of 
glucose from intestine via inhibition of Na+-dependent glucose transporters, SGLT1 and 
SGLT2 (Kobayashi et al., 2000; Jhonston et al., 2005). Some investigations have shown 
that polyphenolic compounds are also able to regulate postprandial glycemia and inhibit 
the development of glucose intolerance by a facilitated insulin response and attenuated 
secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like 
polypeptide-1 (GLP-1) (Jhonston et al., 2003; Dao et al., 2011). Epidemiological studies 
have shown the occurrence of a decreased prevalence and incidence of asthma and an 
enhanced pulmonary function after apple intake. Considering flavan-3-ols, the antibacterial 
activity of catechins is known from the 1990s, when it was demonstrated that these 
compounds, largely present in oolong tea and above all green tea (Camellia sinensis), 
inhibited the in vitro growth of several bacterial species, such as Vibrio cholerae, 
Streptococcus mutans, Campilobacter jejuni, Clostridium perfringes, and Escherichia coli 
(Sakanake et al 1992; Diker et al 1991; Ahn et al 1991; Isogoi et al 1998 and Daglia 2012). 
In order to achieve beneficial effects the maximum polyphenols daily intake is 1g/day 
(Chun et al., 2007). 
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Bioaccessibility and bioavaiability 
Although the biological activity of polyphenols is largely studied, as reported in the last 
paragraph, it is important consider that not all the amounts present in polyphenolic rich 
food or beverage, are available to the intestinal absorption. In order to obtain many effects 
in specific tissues or organs, polyphenols must be available and their bioavailability is 
influenced by several processes that occur in the LADME (Liberation, Absorption, 
Distribution, Metabolism and Excretion) scheme. As shown in this scheme the liberation of 
the bioactive compounds from the food matrix, is a key passage, fundamental to the 
consequently availability. So it is important underlines, that the polyphenols availability is 
not only limited from the enzymatic, mechanical or chemical transformation that happen 
during the gastrointestinal digestion, following by their potential inactivation, but also by 
all processes of splitting the bioactive compounds from the food matrix. So it is correct to 
consider before the bioaccessibility and after the bioavailability. The concept of 
bioaccessibility can be defined as the quantity or fraction of bioactive compounds which is 
released from the food matrix in the GI tract and becomes available for absorption. This 
includes digestive transformations of food into material ready for assimilation, the 
absorption/assimilation into intestinal epithelium cells, and lastly, the presystemic 
metabolism (Fernández-García et al., 2009). After the liberation from food matrix, the rate 
of absorption depending from the chemical structure of the compounds, their 
hydrophobicity, the presence of charge etc. Most of polyphenols are present in food in the 
form of esters, glycosides, or polymers that cannot be absorbed in their native form (low 
hydrophobicity) (Manach et al., 2004) and related to their chemical structures changes the 
absorption site : at gastric level are absorbed flavonols like quercetin, but not its 
glycosidate form, and anthocyanins (Pandey et al., 2009). Most of glycoside resist to 
gastric digestion and arrive untransformed in the intestine. At this level the glycosides 
could be absorbed by enterocyte membrane sodium dependent glucose transporter SGLT1 
and in the enterocyte they are directly hydrolyzed by -glucosidase in aglycone form 
(Passamonti et al., 2005 and D’Archivio et al., 2007). Fourthmore the substances, that 
reach the lower tract of intestine, must be hydrolyzed by intestinal enzymes or by the 
colonic microflora before they may be absorbed. When the intestinal flora is involved, the 
efficiency of absorption is often reduced because the flora also could degrades the 
aglycones producing various simple aromatic acids (Manach et al., 2004; Manach et al., 
1995 and Hollman et al., 1997). The mechanism involved for polyphenols intestinal 
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absorption is the passive passage thought the gut wall, for the hydrophobic molecules, but 
the membrane carriers that could be involved in polyphenolic free form absorption have 
not been identified. To date, the unique active transport mechanism that has been described 
is a Na-dependent saturable transport mechanism involved in cinnamic and ferulic acid 
absorption in the rat (Ader et al., 1996). Later, polyphenols undergo both in the intestine 
and in the liver to highly efficient metabolic conjugation processes (such as methylation, 
sulfation and glucuronidation) that aim to detoxify these xenobiotics (Day et al., 2001), 
increasing their hydrophilicity and promoting their excretion through bile and urine: thus, 
circulating polyphenols are conjugated derivatives, strongly bound to plasmatic proteins, 
especially albumin and the binding force depending by the structural characteristics of the 
phenolic compounds (Manach et al., 2004; Pandey et al., 2009). The digestion would 
change the structure of polyphenolic compounds, and release molecules without biological 
activity, but sometimes, could release molecules that demostrated a new strong biological 
activity. For example, the soy isoflavone daidzein is microbially biotransformed to equol, 
which has a more potent estrogenic action than the precursor itself (Bowey et al., 2003). 
Finally, the sum of all these steps, determines a reduction of polyphenol amount available 
for the intestinal absorption. Bioaccessibility studies have been conducted on grapes, they 
have found 62.4% of total polyphenols were bioaccessible in the simulated pancreatic juice 
while the remaining were in part degraded and in part not extracted from the solid matrix. 
Regarding flavonoids, 56.1% of total flavonoids were bio-accessible in the simulated 
pancreatic juice while only 7.6% of anthocyanins were found in the pancreatic digested 
samples. These different bioaccessibility values between flavonoid and anthocyanins are 
related to their chemical structures. (Tagliazucchi et al., 2010) Flavonoids like cathecin or 
quercetin  are stable at alkaline intestinal pH (loss of catechin of less than 8% in simulated 
intestinal fluid (Neilson et al., 2007; Laurent et al., 2007)), while the low quantity of 
anthocyanins in the simulated pancreatic juice confirms their low chemical stability at 
gastric pH (Pérez-Vicente et al., 2002). 
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Fig. 8: Routes for dietary polyphenols and their metabolites in humans. Within the host, 
dietary polyphenols and their microbial metabolites successively undergo intestinal and liver Phase 
I and II metabolism, biliary secretion, absorption in the systemic circulation, interaction with 
organs and excretion in the urine (Cardona et al., 2013). 
 
 
1.2.5 Polyphenols contained in apples 
The apple is an important source of polyphenolic compounds. A lot of studies were 
produced to identity and characterize the apple’s polyphenolic composition, particularly 
flavonoids (the major phenolics in apples) and related total antioxidant activities based on 
chemical extraction, typically using methanol or water/methanol mixtures (Lamperi et al., 
2008; Lee et al., 2003; Neveu et al., 2010 and  Wojdylo et al., 2008). It is difficult to 
performs a unique characterization of apple polyphenols, fix a unique profile. The 
qualitative profile depended from the different cultivars studied, and the amount of single 
molecules analyzed is distributed in different way between the pulp and the peel (Tsao et 
al., 2003 and Lamperi et al., 2008). In general, the concentration of polyphenols is major in 
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the peel than in the palp. It is normal, because the peel is the defense organ of the fruit, and 
a part of polyphenols have a protection activity against the external attacks. In general the 
apple polyphenolic profile is characterized by the presence of compounds belonging to the 
following classes: flavanols, flavonols, anthocyanins, hydroxycinnamic acids and 
dihydrochalcones (Alonso-Salces et al., 2004). 
Flavonols are mostly represented by quercetin derivatives : as hyperin (quercetin-3-O-
galactoside), isoquercitrin (quercetin-3-O-glucoside), rutin (quercetin-3-O-rutinoside), 
avicularin (quercetin-3-O-α-arabinofuranoside) and quercitrin (quercetin-3-O-rhamnoside). 
These compounds have a maximum UV absorbance at 360 nm . 
 
 
 
 
Fig. 9: Quercetin structure 
The Chlogenic acid (4-p-coumaroylquinic acid) is the most representative Hyroxycinnamic 
acid, it is the 4 % to 18% of apple polyphenols, and has two UV Absorbance maximum : 
280 and 360 nm. 
 
 
 
 
 
Fig. 10: Chlogenic Acid structure 
The anthocyanins are characterized by strong red color, in fact they are present mostly in 
the apple with brilliant red or dark peels. According to these feature they present a 
maximum UV absorbance at 520 nm. The anthocyanins present in higher concentration in 
apple, are glycoside derivative of cyaniding  (cyanidin-3-O-galactoside). 
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Fig. 11: Cyanidin-3-O-galactoside structure 
Among flavanols the most representative are (71-90% of total polypheolic content) : (-)-
epicatechin and (+)-catechin.  According to their structures, they have a maximum 
absorbance at 280 nm. 
 
 
 
 
 
Fig. 12: (+)Catechin structure 
These compounds are present in polymerized form : the procyanidins (polimeralization of 
catechin and epicatechin). The polymeric procyanidins are constituted by a repetition of 
the same base units, and according to the number of repetition the procyanidyns can be 
divided in 5 class: dimeric (n=2) Procyanidin B2-B8 and A1-A2. In B-type procyanidins, 
monomeric units are connected through a single C4-C8 or C4- C6 linkage, while A-type 
procyanidins have an additional C2-O-C7 or C2-O-C5 linkage (Fig. 13) . The monomeric 
units could reach higher polymerization grade to form a trimeric (n=3 C1 and C2) (Fig.12), 
tetrameric, pentameric, and high molecular weight procyanidins when its structure is 
formed by more base unit (6< n<11). (Appeldoon et al., 2009) 
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Fig. 13: Different structures of dimeric Procyanidins ( Bombardelli and Marazzoni, 1995). 
 
A C 
B 
A C 
B 
Procyanidin B1 : R1 = OH, R2 = H                                        Procyanidin B3 : R1 = OH, R2 = H 
Procyanidin B2 : R1 = H, R2 = OH                                        Procyanidin B4 : R1 = H, R2 = OH 
                                      
 
 
Procyanidyn B5: R1 = H, R2 = OH                     Procyanydin B6 : R1 = OH, R2= H 
Procyanidyn B7: R1 = OH, R2 = OH                  Procyanidin B8 : R1 = OH, R2 OH 
 
 
A 
B 
C 
A 
B 
C 
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Fig. 14: Trimeric procyanidin structures. 
A comparative study about the phenolic composition in different apple cultivars has been 
performed by Tenore et al.(2013a), which showed that, the Annurca apple has a higher 
total phenol content than other cultivar studied : Pink Lady, Red delicious, Golden 
Delicious, Fuji and Granny Smith (Annurca’s total phenol content is 135.32 mg/100g FW 
and 101.57, 95.87, 45.27, 32.13 mg/100g FW are the concentrations present respectively in 
Red Delicious, Granny Smith, Fuji and Golden Delicious cultivar). Particularly, the data 
that attract my attention is the extraordinary amount of procyanidin B2 in this apple 
cultivar 62.91 mg/100g FW against a lower concentration in the other studied cultivar. 
These data are linked to the particular protocol of ripening. According to PGI guide line, 
the Annurca apples are harvested when they present a green- yellow peel, and the repining 
are completed on the ground for 15 days. During this period the peel color change until to 
be dark red and the concentration of phenolic compounds tends to increase. This effect 
could be due to the ethylene action, a hormone able to stimulate the activity of 
phenylalanine ammonia lypase (PAL), which is the most important enzyme in polyphenol 
biosynthetic pathway. Consequently, the antioxidant activity of peels increases during the 
reddening process, so polyphenols coming from Annurca are considered relatively stable 
and maintain health benefits also after storage (D’Angelo et al., 2007).In the last years on 
Procianydin B2 was addressed particular interest for its peculiar chemopreventive actions 
and strong effects on the metabolic syndrome (Tenore et al., 2013a,b;2014). Thus, in this 
study, I have used largely the annurca apple as source of phenolic extract, particularly rich 
in procyandin B2, to evaluate and explore new potential nutraceutical applications. In the 
following chapters will be shown different applications and formulations of this precious 
fruit and its valuable polyphenolic content. 
 
         Procyanidin C2                     Procyanidin C1 
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Chapter 1 
 
Functional food formulation 
Annurca apple puree enriched with different strains of acid lactic bacteria as a potential 
functional food: In vitro and in vivo studies 
1.1 Introduction  
Probiotics are defined as live microbial food supplements, which upon ingestion in 
sufficient quantities exert health benefits including the improvement of the intestinal 
microbial balance (Menrad, 2003). The consumption of foods and beverages containing 
functional probiotic microorganisms is a growing, global consumer trend (Verbeke, 2005). 
Encouraged from this new global tendency, I projected a new potential functional food : 
LactoFermented Annurca apple puree .This product was a symbiotic system, composed of 
two different actors : the prebiotic matrix (Annurca apple puree) and the probiotic strains.  
This project could be considered as an unusual study of bioaccessibility, which is normally 
evaluated by in vitro digestion procedures. This parameter was examined from another 
point of view : how the fermentation by acid lactic bacteria would improve the amounts of 
free phenolic compounds released from the fiber, mainly represent by pectin in Annurca 
apple puree. This study was aimed to increase the polyphenolic bioaccessibility, that is 
normally limited from several factors. It's commonly known that the association of 
polyphenols with dietary fiber rich food, caused a decrease of bioaccessibility of ingested 
polyphenols in gastric and small intestinal digestion because they form a specific and 
unspecific bond with the fiber (Hagl et al., 2011; Manach et al., 2004; Saura-Calixto et al., 
2007). The Polyphenolic bioaccessibility is not only limited by different diet associations, 
therefore, in vegetable and fruit it is limited by the interaction with the food matrix and 
mainly with polysaccharides cell wall (PCW). The interactions between polyphenols and 
plant cell walls can occur spontaneously and extensively, as soon as polyphenols come into 
contact with either plant cell wall analogues (e.g. cellulose, cellulose/pectin) (Padayachee 
et al., 2012a,b) or PCW materials (Bindon et al., 2010; Renardet al., 2001). Several studies 
have investigated the interactions between procyanidins and model polysaccharides, that 
represent cell wall components (Bourvellec et al., 2005; Ruiz et al., 2014). In agreement 
with these studies were possible various type of interactions between polyphenols and 
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PCW, and they derive from the structure of the phenolic compounds and the 
polysaccharides constituents of the PCW. In particular, in the apple puree, the pectin was 
the most abundant component of apple fiber. As some studies showed, a gel-like pectin 
model preferentially interacts with procyanidins with a greater apparent binding affinity 
than xyloglucan and cellulose (Le Bourvellec et al., 2005). In addition, Padayachee et al. 
(2012a,b) contributed to the current understanding of the mechanism for the binding 
selectivity of polyphenols to different PCW components through an investigation of the 
interactions of anthocyanins and phenolic acids in purple carrot juice with either cellulose 
or cellulose-pectin composites. Padayachee’s study found that polyphenols selectively and 
extensively bind to different types of cell wall components, normally present in the 
primary PCW, with the saturated binding levels predicted to be in the range of 0.3–1.5 g 
adsorbed polyphenols/g dry weight of PCW. It can be inferred that a high proportion of 
ingested polyphenols might be bound to cell walls (dietary fiber) in plant-based food 
products, during food processing, preparation, and consumption, whenever polyphenols 
have the opportunity to come into contact with the PCW. In fact, the interaction between 
polyphenols and PCWs may occur quickly in real food systems, since the binding 
phenomenon happens spontaneously under the practical conditions of the food processing 
of several common food products such as wine (Bindon et al., 2013), fruit juice (Le 
Bourvellec et al., 2007), or after consumption inside the human digestive tract (Hagl et al., 
2011; Manach et al., 2004; Saura-Calixto et al.,2007). Importantly, if the binding is 
relatively stable, with limited bioaccessibility during gastric and small intestinal digestion 
(Hagl et al., 2011; Mandalari et al., 2011; Padayachee et al., 2012), many polyphenols 
might be carried by PCW materials to the large intestine, where they would be expected to 
be released/metabolized by the resident microbiota (Fogliano et al., 2011; Scalbert et al., 
2002). Taking inspiration from this last concept, I formulated the Lactofermentated 
Annurca apple puree, it is a prototype of functional food, where the probiotic activity is an 
arm to increase the theoretical polyphenols bioaccessibility, that conjugated with probiotic 
activity, could reduce the blood concentration of TMAO (trymethilammine-N-oxide). This 
molecule is considered a new risk factor of cardiovascular disease with a linear correlation 
between the TMAO  blood concentration and cardiovascular events (Mente et al., 2015). 
Per blood concentration < 2.43 M, is associated a low risk of cardiovascular diseases, 
moderate risk for concentration between 2.43 and 3.66 M, high risk between 3.66 and 
6.18 M and very high risk for TMAO concentration > 6.18 M (Wilson et al., 2013). 
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TMAO is a secondary metabolite produced in two-steps process. Firstly, its precursor 
TMA (trimethylamine) is derived in vivo from the gut-microbial cleavage of 
trimethylamine spices such as choline and carnitine or phosphatidylcholine (Ufnal et al., 
2015). Choline is absorbed by the small intestine through a carrier saturated at a 
concentration of 200-300 micromolar (Sheard et al., 1989), when the carrier was saturated, 
choline excess reaches crass intestine and it was metabolized by intestinal bacteria to form 
TMA (trimethylamine)(Wang et al., 2011)  and the major part of TMA produced, passed 
into the bloodstream and then rapidly oxidized to TMAO by FMO3 a liver isoform of 
flavin monooxygenase (FMO, Flavin-containing monooxygenase) (Warrier et al., 2015). 
The formation of this molecule was a multi-factorial event, is related to the diet habits 
(high consumption of red meat, eggs, fish) and gut microbiota composition (Wang et al., 
2011). The effects of association between apple polyphenolic content and acid lactic 
bacteria were studied both in vitro (increase of free phenolic compounds and antioxidant 
activity) and in vivo (valuation of blood concentration of TMAO). 
 
 
1.2 Material and mhetods  
Lactobacillus plantarum  and  Lactobacillus rhamnosus ATCC 11982 (Farmalabor, 
Canosa, Italy) were reactivated by culturing twice in MRS broth (meat peptone 10.0 gL−1; 
dextrose 20.0 gL−1; yeast extract 5.0 gL−1; beef extract 10.0 gL−1; disodium phosphate 
2.0 gL−1; sodium acetate 5.0 gL−1; ammonium citrate 2.0 gL−1; magnesium sulfate 0.1 
gL−1; manganese sulphate 0.05 gL−1; Tween 80 1.0 gL−1) (Thermo scientific, Whalthan, 
Massachusetts, USA) at 37 ◦C for 18 h. Pellets were washed in sterile physiological 
solution (NaCl 8.5 gL−1) and suspended in 5mL the same solution. 
 
1.2.1 Annurca apple collection 
Annurca (Malus pumila cv Annurca) apple fruits (each weighing about 100 g) were 
collected in Valle di Maddaloni (Caserta, Italy) in October when fruits had just been 
harvested (green peel). The fruits were reddened, following the typical treatment (Lo 
Scalzo et al., 2001) for about 30 days, and then used for the preparation of apple puree. 
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1.2.2 Annurca apple puree preparation 
The whole (pulp and peel) Annurca apples were cut, homogenized with boiling water in 
ratio (1ml :1 g) until to achieve a good consistence and a smooth puree. It was sterilized for 
15 min at 121°C. 
 
1.2.3 Fermentation of Annurca apple puree 
Fermentation experiments were conducted in test tubes, each of them containing 30 mL of 
apple puree and in sterile conditions. All samples were inoculated with two 18 h cultures 
(final concentration 2.5 and 5x10
6 
CFU
 
/mL) and incubated at 37 ◦C. The control puree 
was also incubated and stored under the same conditions where the volume of inoculum is 
replaced by the same volume of sterile physiological solution (NaCl 8.5 gL−1). The 
samples were left in incubation for 24 and 48 h at 37°C. 
 
1.2.4 pH measurement  
After the incubation time 24 and 48 h, the tubes were opened and the pH was measured by 
pH meter (Crison, Barcellona, Spain). 
 
 
1.2.5 Biochemical analysis 
Apple puree samples were centrifuged at 11 × g for 10min (Biofuge, Beckman, Los 
Angeles, CA, USA). The supernatant was filtered through 0.45 m nylon syringe filter 
(Phenomenex ,Torrance, CA, USA, ) and used for biochemical analyses. 
 
1.2.6 Antioxidant activity 
The antioxidant activity of annurca apple puree was measured with respect to the radical 
scavenging ability of the antioxidants present in the sample using the stable radical 2,2-
diphenyl-1-picrylhydrazyl (DPPH) (Sigma-Aldrich St. Louis, MO, USA). The analysis 
was performed by adding 50 μL of the apple puree supernatant to 950 μL of a methanol 
solution of DPPH (153 mmol L−1). The decrease in absorbance was determined with a 
UV-visible spectrophotometer (Beckman, Los Angeles, CA, USA). The absorbance of 
DPPH radical without antioxidant, i.e., the control, was measured as basis. All 
determinations were in triplicate. Inhibition was calculated according to the formula [(1− 
Af /Ab)] × 100, where Af is the absorbance after 6min, and Ac is the absorbance of the 
blank at time zero. (Brand-Williams et al., 1995). 
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1.2.7 Total Polyphenol Content 
Total polyphenol content (TPC) was determined through Folin-Ciocalteau’s method, using 
gallic acid as standard (Sigma-Aldrich St. Louis, MO, USA). In brief, the 0.1 mL of 
samples (properly diluted with water in order to obtain an absorbance value within the 
linear range of the spectrophotometer) underwent an addition of: 0.5 mL of Folin-
Ciocalteau’s (Sigma-Aldrich St. Louis, MO, USA) reagent and 0.2 mL of an aqueous 
solution of Na2CO3 (20%; w/v %), bringing the final volume to 10 mL with water. After 
mixing, the samples were kept in the dark for 90 min. After the reaction period, the 
absorbance was measured at 760 nm. Each sample was analyzed in triplicate and the 
concentration of total polyphenols was calculated in terms of gallic acid equivalents  
(GAE) (Di Lorenzo et al., 2015). 
 
1.2.8 Study population and protocol 
The study was a multicentered, placebo-controlled trial, conducted at the Samnium 
Medical Cooperative and the UCCP center (Benevento, Italy). Participants in the study 
were recruited by the Cooperative Medica Samnium and the UCCP Center (Primary Care 
Complex Unit) (Benevento, Italy). Patients were recruited in April 2017. Patients between 
the ages of 18 and 70 had baseline values of cholesterol values outside the optimal values: 
TC 200-260mg / dL; HDL-C 30-45mg / dL; and LDL-C 189-206mg / dL. Subjects were 
asked to keep their eating habits unchanged throughout the study and to compile a Food 
Frequency Questionnaire (FFQ) to provide information on their eating habits. Exclusion 
criteria were as follows: pregnant women, women suspected of being pregnant, women 
who tried to undergo a pregnancy, women in the breast-feeding period. Subjects received 
oral and written information about the study before giving their written consent. All 
patients underwent a standardized Physical Examination based on body weight 
measurement and waist circumference and BMI evaluation, an assessment of medical 
history (up to 5 years before enrollment), and blood analysis. Volunteer's protocol and  
letter, and synoptic documents on the study were presented to the scientific committee of 
scientific ethics at AO Rummo Hospital (Benevento, Italy). The study was approved by the 
committee and carried out in accordance with the Helsinki Declaration of 1964 (as revised 
in 2000). 
The duration of the study was 16 weeks: all subjects were undergoing 4 weeks of placebo 
treatment, followed by 8 weeks of treatment and 4 weeks of follow-up. Clinical visits and 
blood collection samples were performed after 12 hours of fasting at weeks 0, 4, 12, 16. 
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All blood samples were taken in the morning. Subjects were advised not to drink alcohol or 
to perform intense physical activity within 48 h before blood sampling. The blood samples 
was collected in 10 mL EDTA tubes (Becton-Dickinson, Plymouth, UK) and the plasma 
was isolated by centrifugation (20 min, 2200 g, 4 ° C). All samples were stored at -80 ° C 
until analysis. Plasma levels of TMAO are analyzed by LC-MS system.  
 
1.2.9 Randomization, concealment, and blinding 
A total of 56 eligible patients were randomly assigned to three groups to receive simple 
apple puree (control), fermented apple puree and a Lactobacilli capsules, these three 
different treatments were coded with different colors and given in random order. The code 
was not broken until all analyses were completed and the results were analyzed 
statistically. If a patient dropped out before receiving functional food, he or she was 
replaced by the next eligible patient enrolled at the same center. The concealed allocation 
was performed by an Internet-based randomization schedule, stratified by study site. The 
random number list was generated by an investigator with no clinical involvement in the 
trial. Patients, clinicians, core laboratories, and trial staff (data analysts, statisticians) were 
blind to treatment allocation. 
 
1.2.10 Study treatments 
The group of 53 patients ( 30–83 years of age) was randomly divided into three subgroups 
(14,16 and 23 subjects). The three subgroups were instructed to drink 120 mL of fermented 
apple puree, 120 mL of simple apple puree or a not-gastroprotect capsules of Lactobacillus 
mix per day. Noteworthy, the daily dose of apple puree, adopted for the clinical trial, was 
in full accordance with the maximum polyphenolic intake (1000 mg), through food 
supplements and novel foods, indicated by the revised form (January 2015) of the 
Commission Regulation (EC) No. 258/1997 as the safe polyphenolic daily amount 
compatible with a good health state.  
A group of 14 subjects, who have been given the indication of taking 125mL of lacto-
fermented pure. Puree was supplied weekly in 1000g packs and stored at 4°C during the 
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week treatment, these samples were prepared by addition of Lactobacilli in concentration 
of 2.5x10
6
CFU/mL, 24h before theirs delivery.  
A group of 23 subjects took a not-gastroprotected capsules of Lactobacilli (Lb. rhamnosus 
and Lb. plantarum 50:50) formulated to contain the same amount of bacteria used for the 
preparation of daily apple puree dose. The capsules were given to subjects weekly (7 
capsules), and during the treatment were stored at 4°C. 
The third group of 16 subjects took 125mL simple apple daily. Puree was supplied weekly 
in 1000g packs and stored at 4°C during the week treatment. 
At the end of the 8-week treatment, a month of follow-up was performed, during subjects 
stopped taking the capsules and puree. 
 
 
 
Fig. 15: Study ﬂowchart, according to the consolidated standards of reporting trials (CONSORT). 
The diagram shows enrolment and primary eﬃcacy endpoints based on patient diaries, from pre-
screening to data collection, and the extent of exclusions, loss to follow-up and completeness of 
diary documentation available across the entire trial period. CPL, capsule of Lactobacillus; NLP, 
Not Lactofermented Puree; LP, Lactofermented Puree. FAS, full analysis set. 
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1.2.11 Study outcomes and data collection 
The unique endpoint measured was the TMAO blood levels. 
 
1.2.12 Safety 
The product is made from apple puree, each weekly dose contains approximately 1,2g of 
polyphenolic extract (daily dose of 170 mg). For clinical trials, puree’s polyphenolic 
content is in full compliance with the maximum daily intake of polyphenolic extract (1000 
mg), via dietary supplements and novel foods, as indicated by the updated version (January 
2015) of Regulation (EC) No. 258/1997 of the Commission, as a safe and healthy state of 
polyphenolic quantity. 
 
1.2.13  TMAO LC-MS Analysis 
To 80 L of plasma were added 160 L of methanol. The mixture are vortex for 2 min, 
and after centrifuged at 12.000 rpm. The supernatant was collected, and used for the LC-
MS analysis. 
The quantitative analysis was performed by LC-MS. The HPLC system Jasco Extrema LC-
4000 system (Jasco Inc., Easton, MD)  has a DAD detector coupled with Advion 
Expression mass spectrometer (Advion Inc., Ithaca, NY). For the identification (ESI) 
source has to operate in positive ion mode. For separation of the analytes a Luna Hilic (5 
particle size, 150x3mm) and security guard colon both supplied by Phenomenex (Torrance, 
CA, USA,) were used. The column temperature was maintained at 60 °C during analysis. 
Mobile phase composition comprised (A) 0.15% formic acid in water containing a final 
concentration of 10 mM ammonium acetate and (B) 100% methanol (LC/MS grade) in the 
ratio 80:20 (A:B), run isocratically at a flow rate of 0.35 mL min1 for 6 min, with a 5 l 
injection volume. After use, the column was stored in 100% acetonitrile and was routinely 
cleaned according to the manufacturer's instructions. TMAO is identified and quantified  
by analytical standard (Sigma-Aldrich St. Louis, MO, USA) calibration curve (Beal et al., 
2016) 
 
1.2.14 Statistical analysis 
All of the experimental data were expressed as mean ± standard deviation (SD) of at least 
five replications. Statistical analysis of data was carried out  by the Student’s t test or two-
way ANOVA followed by the Tukey–Kramer multiple comparison test to evaluate 
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significant differences between a pair of means. The level of significance (α-value) was 
95% in all cases (P < 0.05). The degree of linear relationship between two variables was 
measured using the Pearson product moment 
 
 
1.3 Resultes 
1.3.1 Ph reductions 
Two strains of acid lactic bacteria were used in my study : L.rhamnosus and L.plantarum. 
No general agreement has been reached regarding the concentration of probiotics 
necessary to achieve beneficial effects; usually counts from 10
6
 to 10
8
 CFUmL−1 are 
recommended (Shah 2001). In agreement with this guidelines were projected  two possible 
formulations with different probiotic concentrations. The first with a starting probiotic 
concentration of 2.5 CFU x10
6 
/mL and a second of 5 CFU x10
6 
/mL. The pH values were 
measured at T0 (time of puree preparation) and after 24 and 48 h of incubation for both the 
strains tested. A linear decrease of the pH was observed in both the products, with a 
reduction proportional to the time of incubation and the number of acid lactic bacteria 
added to the apple puree. This event let me hypothesize about a forceful fermentative 
action of the two strains, capability was more evident for L. rhamnosus, which caused a 
higher reduction of pH compared to the effect of L.plantarum calculated as % pH decrease 
against the control (the same volume of puree incubated in the same condition of the 
inoculated products). The data were shown in the following figure 16, where were reported 
the values of the pH of 120 mL of apple puree, measured after 24 and 48 h of the 
incubation, in relation to the number and the strain of Lacatobacillus used. For the 
L.rhamnosus, were obtained a decreases of 10.24% (2.5x10
6
CFU/mL) and 15.18 % (5x10
6 
CFU/mL
 
) after 24 h of incubation at 37°C and respectively 11.00% and 17.45% after 48h 
of incubation. For the L.plantarum the data obtained were the following: reductions of 
5.40% and 9.64% after 24 h pass to 9.01% and 12.94% after 48 h, respectively for the 
incubated products 2.5x10
6
CFU/mL and 5.0x10
6
CFU/mL. My results are in agreement 
with other study which suggested a pH decrease of prebiotic matrix after probiotic 
fermentation, caused by the formation of short chain fatty acid (Nazzaro et al., 2009 and 
2008)  and that vegetable and fruit juices could be a good media for the probiotic growing 
(Babu et al., 1992, Yoon et al., 2006 and  2015). 
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Fig. 16: pH values of two different probiotic starting concentration of Annurca apple puree fermented 
products (2.5 UFC x106 /mL and  5 UFC x106 /mL in 120 mL of apple puree) and the control. Data are the 
means ± SD (n = 3). Results were significantly different at a level of P = 0.001. abcdMean values with 
different superscript letters are significantly different by the Tukey-Kramer multiple comparison test 
 
 
2.5x10
6 
CFU/mL     5x10
6 
CFU/mL       Control 
2.5x10
6 
CFU/mL     5x10
6 
CFU/mL       Control 
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1.3.2 Antioxidant activity and total phenol content of fermented products  
The capacity of two tested strains to increase the bioaccessibility of phenolic compounds 
were evaluated by two different types of test. The antioxidant activity of annurca apple 
puree was measured with respect to the radical scavenging ability of the antioxidants 
present in the sample using the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 
the total polyphenol content (TPC) was determined through Folin-Ciocalteau’s method. 
These tests were performed on the apple puree supernatant, within could be a possible 
enrichment of free phenolic compounds, released from the matrix after the probiotic 
fermentation. The data regard the antioxidant activity and the total polyphenolic content 
were shown in the following table. 
 
Starting 
Concentration 
(CFU/mL) 
 
Incubation time (h) 
% increase of 
antioxidant activity * 
% increase of total 
polyphenols content** 
L.rhamnosus  
2.5x10
6 
CFU/mL 
24 11,89 ± 3,96*** 40,12± 5.6 
L.rhamnosus  
2.5x10
6
 CFU/mL 
48 13,30 ± 3,26 18,67 ± 3,96 
L.rhamnosus 
5x10
6
CFU/mL 
24 nd 1,34 ± 5,7 
L.rhamnosus 
5x10
6
CFU/mL 
48 nd 2,93 ± 7,9 
L.plantarum 
2.5x10
6
CFU/mL 
24 nd 7‚59 ± 6,94 
L.plantarum 
2.5x10
6
CFU/mL 
48 nd 8‚88 ± 8,16 
L.plantarum 
5x10
6
CFU/mL 
24 nd 6‚64 ± 8,40 
L.plantarum 
5x10
6
CFU/mL 
48 nd 3‚79 ± 2,70 
 
Table 2:*% increase of antioxidant activity was calculated against the control and expressed in 
M TE (trolox equivalent).**% increase of total polyphenols was calculated against the control 
and expressed in mgEGA (Gallic acid mg equivalent/120 mL of puree).*** Values are means ± SD 
(n = 3). 
 
According to these results, the best solution was obtained by the incubation, of 
L.rhamnosus than L.plantarum, with an important increase of the free phenolic compounds 
(40.12%) against the 7.59% of the L.plantarum fermented products. The same seems for 
the antioxidant activity, where the higher increase was registered in L.rhamnosus 
fermented products (11.89% after 24h and 13.30 after 48 h). It is very important to 
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evaluate these results are not only linked to the strains tested, but also to the starting 
concentration using for the fermentation (2.5 and 5x10
6
CFU/mL). These concentrations 
were chosen according to the recommendation for probiotic foods: minimal counts of 7. 
Log CFU/mL for better efficacy in regulating beneficial effects (Vinderola et al., 2000). 
The probiotic concentration tends to increase during the incubation time, to reach a 
concentration of  8/8.5 Log CFU/mL (Perera et al., 2011). For the products with an initial 
concentration higher (5x10
6
 CFU/mL), were shown a not important increase of free 
phenolic compounds and a decrease of the antioxidant activity. These events were linked to 
the degradation of polyphenols by too high concentration of acid lactic bacteria. (Lee et al., 
2006 and Tzounis et al., 2011). According to the data reported in the table n°2, there were 
several  formulations characterizated by an increase of total phenols content  against an 
absence of antioxidant activity increase .This event could be explained by the antioxidant 
activity test used: The DPPH test measure. This assay is based on the chromophoric 
changes measurable at 515 nm that accompany reaction of the DPPH radical with a 
hydrogen or an electron donor. But not all the different classes of polyphenols have the 
same hydrogen donator attitude. In same studies a good correlation was found between the 
percentage of reduced DPPH and the concentration of total flavan-3-ols (R = 0.77). On the 
contrary, hydrogen donor ability was not apparently related to the content of 
dihydrochalcones (R = 0.46) or hydroxycinnamates (R = 0.17) (Panzella et al., 2013). 
Others authors, therefore, indicate a greater DPPH scavenging activity of procyanidin B2 
and epicatechin respect to chlorogenic acid. (Carbone et al., 2011). I could hypothesize 
according to the last affirmation, that cinnamic acid derivatives or dihydrochalcones were 
released from the matrix and not degraded by the lactic fermentation. Thus  it was possible 
to observe an increase of total phenolic content, against a not increase of antioxidant 
activity. 
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1.3.3 Blood TMAO concentration 
The  TMAO hematic concentration after treatment (60 days) of involved patients are 
present in the following table : 
 
In Patients treated  with simple puree was registered a decrease in TMAO levels of 42.3%, 
and this effect is amplified by the addition of Lactobacillus in lacto-fermented  puree, 
63.12% of decrease was registered in subjects treated with this product, while 
Lactobacillus alone contributed to a less pronounced lowering of 25.8%. These results 
could suggest a possible relation between the increased polyphenols bioaccessibility and 
TMAO metabolism. 
 
1.4 Discussion 
The idea which inspired this project is aimed to realize a probiotic juice, where acid lactic 
bacteria, were inoculated and growth in Annurca apple puree. This apple cultivar, as 
reported above, is largely studied for its important beneficial effects linked to its particular 
polyphenolic composition. These product could be considered like a “reinforce” apple 
puree, thanks to the more abundant free phenolic compounds. Therefore this potential 
functional food was a no diary source of acid lactic bacteria, the strains used are L. 
rhamnosus and L.plantarum. These bacteria were added to apple puree in two different 
start concentrations 2.5x10
6
CFU/mL and 5x10
6
CFU/mL. The in vitro studies, showed that, 
there was a decrease of pH values, excepted according to saccharolytic activity of 
Lactobacillus. These was related to their ability to degrade the polysaccharides fiber and 
release short chain fatty acid, like : butirryc, lactic, acetic acids (to these compounds are 
ascribed a several bioactivites) (Nazzaro et al. 2009), responsible of the pH decrease. 
Table.3 Effect of functional product on blood levels of TMAO 
  LP Δ% NLP Δ% Capsule Δ% 
TMAO (microM) 
t0      2.1± 0.2 
 
0.02± 0.006 
 
1.7 ± 0.7   
t60   0.8 ± 
0.008 
-63.12 0.01 ± 0.003 -42.3 1.2 ± 0.6 -25.8 
Subjects consumed 120mL of puree or 1 capsule of Lactobacillus for 2 months per day 
Value are means ± SD (n = 5). 
Results are significantly diﬀerent at a level of P = 0.001. 
LP, Lactofermented Puree; NLP, Not Lactofermented Puree; CPL, Capsules. 
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These events were considered, also, as a confirm of the growth of Lactobacillus in this 
food matrix. The best incubation conditions, according to the data obtained, regards to the 
% increase of total phenol content and antioxidant activity was 2.5x10
6
 CFU/mL of 
L.rhamnosus after only 24 h of incubation. In respect of in vitro results, these conditions 
were used to prepare the products for in vivo tests . The clinical trial performed is, only a 
preliminary screening, aimed only to understood the real influence or interference of this 
product on a new parameter, the level of TMAO, causes of atherosclerosis via 
macrophages activation (Wang et al., 2011). Although the patients enrolled didn’t have 
TMAO levels considered dangerous (<2.5 mM), was registered an important decrease of 
blood levels of this molecule. The most significative decrease was achieved, after 
treatment with lactofermented apple puree (-63.12%). This result reflects the data already 
present in the literature, a diet rich in polyphenols  favors a change in the intestinal 
bacterial composition, in favor of saccharolytic bacteria. Administration of extraction 
juices from apples increased fecal counts of Lactobacillus and Bifidobacterium (Sembries 
al., 2006), against other gut microbiota strains such as Clostidium strain that has a strong 
implication in the TMA formation. In fact, Romano et al., 2015  said that, the bacteria able 
to process the choline in TMA were bacteria strains such as : Anaerococcus hydrogenalis, 
Clostridium asparagiforme, Clostridium hathewayi, Clostridium sporogenes, Escherichia 
fergusonii, Proteus penneri, Providencia rettgeri, and Edwardsiella tarda. In patients 
treated with fermented puree was achieved a decrease 1.5 times greater than the results 
obtained in patients treated with simple puree. This data was related to % increase of free 
phenolic compounds released from the pectin, that conducted a bacteriostatic or bactericide 
activity was responsible of lower grade growth of Clostidium at intestinal level (lowering 
TMA formation) (Semla et al., 2009). Therefore these data are associable also, to a 
potential increase of bioavailability confirmed from Pereira-Caro et al.(2015), they 
reported that, chronic administration of probiotic enhances the bioavailability of orange 
juice flavanones in humans of 70%, related to lower growth of sulfate-reducing bacteria 
(SRB) are those bacteria that can obtain energy by oxidizing organic compounds or 
molecular hydrogen (H2) while reducing sulfate (SO2
−4
) to hydrogen sulfide (H2S), it 
means a minor polyphenolic (oxidizing organic compounds) degradation and follow to 
major phenolic bioavailability. It means potential higher polyphenolic blood concentration 
in patients treated with fermented puree, that could exerct their antioxidant activity and 
cause a potential conversion or reduction of TMAO levels. 
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1.5 Conclusions 
The bioaccessibility, and consequential bioavailability of polyphenols are increased 
respectively, thanks to the release of polyphenols from the fiber (bioaccessibility) due to 
fermentation proved by in vitro increase of TC and antioxidant activity, and to the 
inhibition of SRB growth induced by chronic treatment with probiotic (bioavailability). 
The TMAO levels, is influenced by changing and modelling microbiota composition 
related to major intake of polyphenols and probiotic, both present in the same product, and 
from potential major blood polyphenols rate. 
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Chapter 2 
 
Nutraceutical formulations 
2.1 Annurca Apple Nutraceutical Formulation Enhances Keratin Expression in a 
Human Model of Skin and Promotes Hair Growth and Tropism in a Randomized 
Clinical Trial 
 
 
2.1.1 Introduction 
Several pharmaceutical products have been formulated over the past decades for the 
treatment of male and female alopecia and pattern baldness (Kelly et al., 2016). These 
most common forms of hair loss in men and women, affecting approximately 50% of the 
adult population, are non-stop processes which flow toward definite pattern of alopecia in 
genetically predisposed individuals. Although clinically different, the pathogenic pathways 
leading to this type of hair loss are thought to be similar in both sexes (Hoffman., 2002). 
Minoxidil, which was originally synthesized as a potassium channel opener
 
(Buhl et al., 
1993)  and initially prescribed for hypertension, is an FDA approved topical medication for 
curing male pattern baldness (Kulik., 1988 and Olsen., 1989). Recently, finasteride, which 
is a type II 5α-reductase inhibitor and was initially used for has been approved by the FDA 
as an oral drug for male hair loss therapy (Kaufman et al., 1998).  Nevertheless, side 
effects have been reported for both agents ,thereby, considerably limiting their clinical use 
(Wilson et al., 1991; Boek et al., 1996; Nikel et al. 1996;Wilton et al., 1996). In this 
perspective, the pharmaceutical and medical attention has recently focused on the 
discovery of new and safer remedies. Particularly, in search of biological products which 
possess hair growing activity, great interest has been attracted by oligomeric procyanidins, 
extracted from grape seeds, able to promote hair epithelial cell growth as well as to induce 
anagen phase, at almost the same intensity of minoxidil (Takaheshi et al., 1999). 
Specifically, procyanidin B2 has demonstrated to be one of the most effective and safest 
natural compound in promoting hair growth, both in vitro
 
(Kamimura et al., 2002) and in 
humans by topical applications (Kamimura et al., 2000 and Takahashi et al. 2001).  During 
hair growth and keratinisation process along the hair fiber, several keratins arrange into 
filaments to contribute to the production of the hair shaft (Makar., 2007). As ascribed 
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above, apple fruits of cv Annurca (AFA), native of Southern Italy, has the highest contents 
of oligomeric procyanidins, and, specifically, of procyanidin B2, with respect to more 
common apple samples, such as Red Delicious, Granny Smith, Pink Lady, Fuji, and 
Golden Delicious (Tenore et al., 2013). Encouraged by these results, the second aim of the 
present work was to explore the bioactivity of AFA polyphenolic extract, highlighting the 
effects of its supplementation on cellular keratin expression by targeted bioscreen in vitro. 
For this reason, we focused on a well-characterised human experimental model of adult 
skin based on normal human keratinocyte (HaCaT cells)(Miniaci et al. 2016). This cell line 
retains a capacity for differentiation similar to normal human epidermal keratinocytes, and 
hence offers a suitable model for the study of keratinisations as well as of epidermal 
homeostasis (Breitkreutz et al. 1998). Then, the second goal was to evaluate the effects of 
AFA extract supplementation as a nutraceutical, on the hair growth and tropism in healthy 
subjects. To this regard, according to our previous knowledge about the effects of salivary 
and gastric digestion on the bioaccessibility of active components, was used a specific 
formulation consisting of gastro-protected capsules. (Tenore et al. 2013b) 
The present part of my thesis work shows, for the first time, the impact of procyanidin B2, 
contained in apple natural extract, on keratins biosynthesis in vitro, and represents the first 
attempt of its oral administration to humans as potential hair growing nutraceutical agent.  
2.1.2 Materials and method 
2.1.2.1 Apple collection 
Annurca (M. pumila Miller cv Annurca) apple fruits (each, about 100 g) were collected in 
Valle di Maddaloni (Caserta, Italy) in October when fruits had just been harvested (green 
peel). The fruits were reddened, following the typical treatment for about 30 days (Lo 
Scalzo et al., 2001) and then analyzed.  
2.1.2.2 Preparation of AFA supplements (AMS and AMSbzs)  
AFA (whole fruits, peel and pulp) have been repeatedly extracted with water, the obtained 
solution has been filtered, centrifuged, and concentrated. Then, the solution has been spry-
dried in combination with maltodextrins, obtaining a fine powder named AppleMetS 
(AMS). As regards the clinical trial, the AFA supplements used in this study consisted in 
two different types of gastric-resistant capsules, containing: 1) AFA polyphenolic extract 
microencapsulated with maltodextrins (400 mg) (AMS); 2) AFA polyphenolic extract 
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microencapsulated with maltodextrins (400 mg), biotin (0.20 mg), selenomethionine (80.0 
µg), and zinc acetate (21.0 mg), named AppleMetS
 
Hair (AMSbzs). The choice of using 
gastric-resistant capsules was due to our previous knowledge about the effects of salivary 
and gastric digestion on the bioaccessibility of bioactive components (Tenore et al., 2013). 
Both supplements were formulated by the Department of Pharmacy, University of Naples 
“Federico II” (Naples, Italy). Large-scale production of both supplements was 
accomplished by MB-Med Company (Turin, Italy).  
2.1.2.3 Cell cultures and treatments 
HaCaT cells, an immortalized, non-tumourigenic human keratinocyte cell line, were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Paisley, UK) 
containing high glucose (4.5 g/L), supplemented with 10% fetal bovine serum (FBS, 
Cambrex, Verviers, Belgium), L-glutamine (2 mM, Sigma, Milan, Italy), penicillin (100 
units/mL, Sigma) and streptomycin (100 μg/mL, Sigma Milan, Italy) at 37 °C in a 
humidified 5% CO2 atmosphere.  
For in vitro experiments, subconfluent cultures of HaCaT cells were incubated in presence 
or not of FBS with a range of AMS concentrations from 0.009 to 2.3 mg/ml for established 
times.      
 
2.1.2.4 In vitro bioscreens 
Before evaluating the biological effects of AFA polyphenolic extract (AMS) on the 
regulation of keratin expression, preliminary experiments were allowed to finalize the 
experimental model and to define specific protocols for suitable in vitro treatments. 
Biochemical and toxicological investigations were thereby performed in order to explore 
AMS bioactivity in human keratinocytes (HaCaT cell line) in vitro, focusing on the 
evaluation of cell viability as well as on cell growth and proliferation following the 
exposure up to 48 h to various AMS concentrations. As follows, optimal experimental 
conditions of cell growth and protein biosynthesis, relative to both extract concentration 
and incubation times, were set up by means of targeted bioscreens. In detail, the 
experimental procedure involved the estimation of a “cell survival index”, arising from the 
combination of cell viability evaluation with cell counting (Vitiello et al., 2015). HaCaT 
cells were inoculated in 96-microwell culture plates at a density of 10
4
 cells/well, and 
allowed to grow for 24 h. The medium was then replaced with fresh medium and cells 
were treated for further 48 h with a range of concentrations (0.009, 0.09, 0.23, 0.46, 0.92, 
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1.68 and 2.3 mg/ml) of extract. Using the same experimental procedure, cell cultures were 
also incubated with cisplatin (cDDP), as a positive control for cytotoxic effects. Cell 
viability was evaluated using the MTT assay procedure, which measures the level of 
mitochondrial dehydrogenase activity using the yellow 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT, Sigma) as substrate. The assay is based on the 
redox ability of living mitochondria to convert dissolved MTT into insoluble purple 
formazan. Briefly, after the treatments, the medium was removed and the cells were 
incubated with 20 μl/well of a MTT solution (5 mg/mL) for 1 h in a humidified 5% CO2 
incubator at 37 °C. The incubation was stopped by removing the MTT solution and by 
adding 100 μl/well of DMSO to solubilize the obtained formazan. Finally, the absorbance 
was monitored at 550 nm using a microplate reader (iMark microplate reader, Bio-Rad, 
Milan, Italy). Cell number was determined by TC10 automated cell counter (Bio-Rad, 
Milan, Italy), providing an accurate and reproducible total count of cells and a live/dead 
ratio in one step by a specific dye (trypan blue) exclusion assay. Bio-Rad’s TC10 
automated cell counter uses disposable slides, TC10 trypan blue dye (0.4% trypan blue dye 
w/v in 0.81% sodium chloride and 0.06% potassium phosphate dibasic solution) and a 
CCD camera to count cells based on the analyses of captured images. Once the loaded 
slide is inserted into the slide port, the TC10 automatically focuses on the cells, detects the 
presence of trypan blue dye and provides the count. When cells are damaged or dead, 
trypan blue can enter the cell allowing living cells to be counted. Operationally, after 
treatments in 96-microwell culture plates, the medium was removed and the cells were 
collected. Ten microliters of cell suspension, mixed with 0.4% trypan blue solution at 1:1 
ratio, were loaded into the chambers of disposable slides. The results are displayed as total 
cell count (number of cells per ml). If trypan blue is detected, the instrument also accounts 
for the dilution and shows live cell count and percent viability. Total counts and live/dead 
ratio from random samples for each cell line were subjected to comparisons with manual 
hemocytometers in control experiments. The calculation of the concentration required to 
inhibit the net increase in the cell number and viability by 50% (IC50) is based on plots of 
data (n = 6 for each experiment) and repeated five times (total n = 30). IC50 values were 
obtained by means of a dose response curve by nonlinear regression using a curve fitting 
program, GraphPad Prism 5.0, and are expressed as mean values ± SEM (n = 30) of five 
independent experiments.  
The evaluation of the relative number of live and dead cells was performed by a MultiTox-
Fluor Multiplex Cytotoxicity Assay (Promega, Madison, WI). Briefly, cells were plated 
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into 96-well plates (5×10
3
/well) and, after the treatments with AMS as before described, 
the solution containing the fluorogenic substrates for the measurements of live-cell and 
dead-cell protease activities was added to the cells. Following 30 min at 37 °C, the 
fluorescence was determined in a Perkin Elmer microplate reader (Perkin Elmer LS 55 
Luminescence Spectrometer, Beaconsfield, UK) using a filter combination with an 
excitation wavelength of 400/485 nm and an emission wavelength of 505/520 nm (slits 5 
nm). Data are expressed as percentage of viable cell versus control cultures. 
 
2.1.2.5 Cell morphology analysis  
Human keratinocyte cell line was grown on 60 mm culture dishes by plating 5 x 10
5
 cells. 
After reaching the subconfluence, cells were incubated for 24 and 48 h with a range of 
concentrations of AMS (0.09, 0.23, 0.46, 0.92 and 2.3 mg/ml) under the same in vitro 
experimental conditions described above, and were then morphologically examined by a 
phase-contrast microscope (Labovert microscope, Leitz). Microphotographs at a 200 × 
total magnification (20 × objective and 10 × eyepiece) were taken with a standard VCR 
camera (Nikon).  
 
2.1.2.6 Preparation of cellular extracts 
HaCaT cells were grown for 48 h in the presence or absence of AMS at different 
concentrations (0.23 and 0.46 mg/ml), as established after preliminary bioscreens. 
Following treatments, protein extracts were prepared according to previously described 
procedure (Achtstaetter et al.,1986). Briefly, cell pellets were lysed at 4 °C for 10 min with 
buffer containing 1% Triton X-100, 5 mM EDTA, in PBS (pH 7.4) containing protease 
inhibitors. After centrifugation at 14,000 × g for 10 min at 4 °C, the supernatant was 
collected as the soluble fraction and stored at -80 °C. The pellet was homogenized at 4 °C 
for 30 min in 1 ml of 10 mM Tris-HCl, pH 7.6, 140 mM NaCl, 1.5 M KCl, 5 mM EDTA, 
0.5% Triton X-100, and protease inhibitors. The supernatant fraction was obtained by 
centrifugation at 15.000 × g for 10 min at 4 °C and then stored at – 80 °C. Protein 
concentration was determined by the Bio-Rad protein assay (Bio-Rad, Milan, Italy) 
(Miniaci et al., 2016). 
 
2.1.2.7 Western blot analysis 
Defined amounts (70 µg) of proteins from soluble cellular extracts were loaded and 
separated on 10% SDS-PAGE and electrotransferred onto a nitrocellulose membrane (GE 
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Healthcare, UK) using a Bio-Rad Transblot (Bio-Rad). Proteins were visualized by 
reversible staining with Ponceau-S solution and destained in PBS. Membranes were 
blocked at room temperature in milk buffer [1×PBS, 5–10% (w/v) non-fat dry milk, 0.2% 
(v/v) Tween-20] and then incubated at 4 °C overnight with 1:250 monoclonal anti-pan 
cytokeratin antibodies (mixture) (Sigma-Aldrich, Milan, Italy) which recognize the 
following human cytokeratins, according to their molecular weight: K1 (68 kDa), K4 (59 
kDa), K5 (58 kDa), K6/K10 (56 kDa), K13 (54 kDa), K8 (52 kDa), K18 (45 kDa) and K19 
(40 kDa). As secondary antibody a goat anti-mouse IgG + IgM (1:5000, Jackson 
ImmunoResearch Laboratories, Baltimore Pike, West Grove, PA) was used. The immune 
complexes were visualized by the ECL chemoluminescence method (ECL, Amersham 
Biosciences, UK) and analysed  by an imaging system (ImageQuant
TM
 400, GE Healthcare 
Life Sciences). Densitometric analyses were conducted using the GS-800 imaging 
densitometer (Bio-Rad). GAPDH antibody (Sigma-Aldrich, Milan, Italy) was used to 
normalize the results. 
 
2.1.2.8 Study population and protocol 
Study participants were recruited by the Samnium Medical Cooperative (Benevento, Italy). 
Patients were enrolled in November 2015. Patients aged 30-83 years were eligible for 
enrolment if they showed evidence of pattern baldness. The subjects were asked to keep 
their dietary habits unchanged throughout the entire study. Exclusion criteria were: 
smoking, obesity (BMI >30 kg/m
2
), diabetes, hepatic disease, renal disease, heart disease, 
family history of chronic diseases, drug therapy or supplement intake for hair growth, drug 
therapy or supplement intake containing apple polyphenols, heavy physical exercise (>10 
h/week), pregnant women, women suspected of being pregnant, women who hoped to 
become pregnant, breastfeeding, birch pollen allergy, use of vitamin/mineral supplements 
2 weeks prior to entry into the study and donation of blood less than 3 months before the 
study. The subjects received oral and written information concerning the study before they 
gave their written consent. Protocol, letter of intent of volunteers, and synoptic document 
about the study were submitted to the Scientific Ethics Committee of AO Rummo Hospital 
(Benevento, Italy). The study was approved by the committee, and carried out in 
accordance with the Helsinki declaration of 1964 (as revised in 2000). The subjects were 
asked to make records in an intake-checking table for the intervention study and side 
effects in daily reports. The study was a monocentric, randomised, double blind, placebo-
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controlled trial conducted at the Samnium Medical Cooperative (Benevento, Italy). The 
study duration was 16 weeks: the group underwent 4 weeks of placebo treatment, 
consisting in the administration of identically appearing capsules containing only 
maltodextrin, followed by 8 weeks of nutraceutical treatment, and 4 weeks of follow-up. 
Both the examinations and the study treatment were performed in an outpatient setting. 
Clinic visits and hair sampling were performed at weeks 0, 4, 8, 12, and 16. Hair counts 
were carried out per area (cm
2
) of a pre-determined site of bald head skin, by three 
independent investigators three times each in double-blind mode. A number of 100 hairs (1 
cm long) were sampled in the neck. Hair were weighed by using a ABJ 320-4NM 
analytical balance (Zetalab Ltd, Padova, Italy). The hair keratin content was evaluated by 
first defatting hair samples with n-hexane and petroleum ether (4:1) for 4 h in a Soxhlet 
apparatus, and then, estimating the protein content according to the Kjieldahl method 
920.87, by using a PBI International model Mineral SIX digester (PBI International, Milan, 
Italy) and a Buchi model B-324 distillation unit (Buchi, Flawil, Switzerland)( Prosky et al. 
1988). Clinic visits, and blood sampling to test hepatic and renal toxicity, were performed 
after 12 h of fasting at weeks 0, 4, 8, 12, and 16. Subjects were informed not to drink 
alcohol or perform hard physical activity 48 h prior to blood sampling. All blood samples 
were taken in the morning and immediately after measurement of heart rate and blood 
pressure. Blood samples were collected in 10-mL EDTA-coated tubes (Becton–Dickinson, 
Plymouth, UK) and plasma was isolated by centrifugation (20 min, 2.200 g, 4 °C). All 
samples were stored at -80 °C until analysis. Plasma AST, ALT, γ-GTP, ALP, LDH, 
albumin, total bilirubin, and creatinine levels, were determined on a Diacron International 
Free Carpe Diem, using commercially available kits from Diacron International (Grosseto, 
Italy). In addition to these five meetings, five standardised telephone interviews were 
performed starting from the first meeting, to verify compliance and increase protocol 
adherence. In particular, these interviews reminded patients to complete their intake-
checking table for the intervention study and to record any discontinuation, or adverse 
events they might have experienced in the meantime (which were also documented 
regularly on the case report forms during each telephone and clinic visit). All patients 
underwent a standardised physical examination, assessment of medical history (for up to 
five years before enrolment), laboratory examination, measurement of blood pressure and 
heart rate, and evaluation of BMI. At each clinic visit, patients had to complete three self-
administered questionnaires on quality of life aspects, and their diaries were checked for 
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data completeness and quality of documentation to ensure patient comprehension of the 
diary items.  
 
2.1.2.9 Randomisation, concealment, and blinding 
A total of 250 eligible patients were randomly assigned to two groups in order to receive 
AMS or AMSbzs supplements. Supplements and placebo were coded with different 
colours and given in random order. The code was not broken until all analyses were 
completed and the results were analysed statistically. If a patient dropped out before 
receiving supplement, he or she was replaced by the next eligible patient enrolled at the 
same centre. The concealed allocation was performed by an internet based randomisation 
schedule, stratified by study site. The random number list was generated by an investigator 
with no clinical involvement in the trial. Patients, clinicians, core laboratories, and trial 
staff (data analysts, statisticians) were blind to treatment allocation. 
 
2.1.2.10 Study treatments 
The group of 250 patients (116 men and 134 women, 30-83 years of age) was randomly 
divided into two subgroups (each one of 125 subjects, 58 men and 67 women). The two 
subgroups were instructed to take two capsules of AMS or AMSbzs per day (one capsule 
in the morning, and one capsule in the evening). Noteworthy, the daily dose of 
polyphenolic extract, adopted for the clinical trial, was in full accordance with the 
maximum polyphenolic extract daily intake (1000 mg), through food supplements and 
novel foods, indicated by the revised form (January 2015) of the Commission Regulation 
(EC) No. 258/1997, as the safe polyphenolic daily amount compatible with a good health 
state. Moreover, the quantities of biotin, selenium, and zinc, have been calculated on the 
basis of what established by the Italian Ministry of Health (DM Revision June 2016) as 
regards the maximum levels of vitamins and minerals allowed in food supplements, in 
accordance with what reported by the current European regulation about the minimum 
daily requirement (Nutrient Reference Values, NRVs) of vitamins and minerals (Reg. UE 
1169/2011). 
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2.1.2.11 Study outcomes and data collection 
Primary and secondary efficacy outcomes. The primary endpoint measured was the 
increase in the hair number/cm
2
 area of bald head skin (> 5% after 30 days, > 10% after 60 
days), while key secondary outcomes were the increase in the weight and keratin content 
of hair samples collected (in both cases: > 5% after 30 days, > 10% after 60 days). All raw 
patient ratings were evaluated in a blinded manner at the site of the principal investigator. 
The decision process was performed according to a consensus document (unpublished 
standard operating procedure) before unblinding in order to define conclusive primary and 
secondary efficacy data from a clinical perspective.  
2.1.2.12 Safety  
Although no specific toxicity studies have been performed herein, mutagenicity tests, 
acute/subacute toxicity studies have long since demonstrated the safety of polyphenol 
content of apples both in mice and human beings. Specifically, the Commission Regulation 
(EC) No. 258/1997 established 1000 mg as maximum polyphenolic extract daily intake in 
humans. Accordingly, the polyphenolic extract dose adopted for the trial was an amount 
reasonably lower than that regarded as safe in humans. Moreover, the daily administration 
of biotin, selenium, and zinc, respected what disposed by the Italian Ministry of Health 
(DM Revision June 2016) as regards the maximum levels of vitamins and minerals 
allowed in food supplements, in accordance with what established by the current European 
regulation about the minimum daily requirement (Nutrient Reference Values, NRVs) of 
vitamins and minerals (Reg. UE 1169/2011). Nevertheless, we assessed safety from reports 
of adverse events as well as laboratory parameters concerning the hepatic and renal 
function, vital signs (blood pressure, pulse, height, weight, and body mass index), and 
physical or neurological examinations. Safety was assessed over the entire treatment period 
at weeks 0, 4, 8, 12, and 16, including adverse events occurring in the first three weeks 
after cessation of treatments. During the test, all subjects underwent a clinical diagnosis by 
a dermatologist, focusing on any adverse dermatological reactions such as inflammation, 
erythema or eczema. 
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2.1.2.13 Statistics 
Methodology. All the in vitro experiments have been repeated four times. Data were 
presented as mean ± SEM and the statistical analysis was performed using Graph-Pad 
Prism (Graph-Pad software Inc., San Diego, CA), and ANOVA test for multiple 
comparisons followed by Bonferroni’s test. During the trial, it became apparent that 
dropouts and incomplete diary documentation created missing data that could not be 
adequately handled by the intended robust comparison. To deal with the missing data 
structure, we used a negative binomial, generalised linear mixed effects model (NB 
GLMM) that not only yields unbiased parameter estimates when missing observations are 
missing at random (MAR)(Little et al. 2002), but also provides reasonably stable results 
even when the assumption of MAR is violated (Molenberghs G et al., 2004; O’Kelly  et al., 
2014). Patients who did not provide any diary data (leading to zero evaluable days) were 
excluded from the MAR based primary efficacy analysis, according to an “all observed 
data approach” as proposed by White and colleagues (White et al., 2012). This approach is 
statistically efficient without using multiple imputation techniques (Carpenter et al., 2007). 
Data retrieved after withdrawal of randomised study treatment were also included in the 
analysis. All of the trial experimental results were expressed as mean ± standard deviation 
(SD) of four replications for each patient. Statistical analysis of data was performed by the 
Student’s t test or two-way ANOVA followed by the Tukey-Kramer multiple comparison 
test to evaluate significant differences between a pair of means. The statistic heterogeneity 
was assessed by using Cochran’s test (p<0.1). The I2 statistic was also calculated, and 
I
2
>50% was considered as significant heterogeneity across studies. A random-effects 
model was used if significant heterogeneity was shown among the trials. Otherwise, results 
were obtained from a fixed-effects model. Percent change in mean and SD values were 
excluded when extracting SD values for an outcome. SD values were calculated from 
standard errors, 95% CIs, p-values, or t if they were not available directly. Previously 
defined subgroup analyses were performed to examine the possible sources of 
heterogeneity within these studies and included health status, study design, type of 
intervention, duration, total polyphenols dose, and Jadad score. Treatment effects were 
analysed using PROC MIXED with treatment (placebo, apple supplements) and period as 
fixed factors, subject as random factor and baseline measurements as covariates, and 
defined as weighted mean difference and 95% CIs calculated for net changes in serum 
parameters and blood pressure values. Data that could not meet the criteria of variance 
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homogeneity (Levenes test) and normal distribution (determined by residual plot 
examination and Shapiro–Wilks test) even after log transformation were analysed by a 
nonparametric test (Friedman). The level of significance (α-value) was 95% in all cases (P 
< 0.05). 
2.1.2.14 Analysis sets 
The full analysis set population included all randomised patients, and patients who did not 
fail to satisfy a major entry criterion. We excluded patients who provided neither primary 
nor secondary efficacy data from efficacy analyses. The per protocol set consisted of all 
patients who did not substantially deviate from the protocol; they had two characteristics. 
Firstly, this group included patients for whom no major protocol violations were detected 
(for example, poor compliance, errors in treatment assignment). Secondly, they had to have 
been on treatment for at least 50 days counting from day of first intake (completion of a 
certain prespecified minimal exposure to the treatment regimen). Hence, patients who 
prematurely discontinued the study or treatment before day 44 were excluded from the per 
protocol sample. 
 
2.1.2.15 Patient involvement  
No patients were involved in setting the research question or the outcome measures, nor 
were they involved in developing plans for participant recruitment, or the design and 
implementation of the study. There are no plans to explicitly involve patients in 
dissemination. Final results will be sent to all participating sites. 
 
 
2.1.3 Results 
2.1.3.1 In vitro bioscreen  
The results are presented in Figure 17 by concentration-effect curves, and clearly prove 
that AMS does not show any significant interference with the cell survival index, even at 
high in vitro concentrations (>0.5 mg/ml). As well, we even report a slight increase of cell 
viability in the presence of low micromolar concentrations of the extract. In line with this 
outcome, inversely correlated fluorescent measurements for the estimation of the live/dead 
cells ratio showed that AMS, for all the screened concentrations and times, does not 
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interfere with the HaCaT keratinocytes viability (see Fig.17-B). In addition and to support, 
we monitored the cellular morphology throughout the in vitro trials. End-points imaging by 
light microscopy were taken from cells to assess potential cellular monolayers 
modifications induced by incubation with different concentrations of the polyphenolic 
extract. The occurrence of changes in cell morphology as well as in monolayers 
appearance are generally suggestive of distinctive hallmarks of cell death pathways 
activation. Accordingly with the cell survival index analysis, AMS proves to be very 
biocompatible, also at high final concentrations and after 48 h of incubation, so that no 
significant modifications of keratinocyte subconfluent monolayers were evidenced (Fig. 
18). In conclusion, in vitro bioscreens suggest the theoretical safety of AMS administration 
to human keratinocytes under a wide range of experimental conditions, thus allowing to 
design further in vitro experiments on viable cells. 
 
 
 
Fig. 17: AMS bioactivity in vitro. (A) Cell survival index, evaluated by the MTT assay and the 
determination of live/dead cell ratio. Human keratinocytes (HaCaT cells) were treated for 48 h with 
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a range of concentrations (from 0.09 to 2.3 mg/mL) of AMS (Annurca apple polyphenolic extract 
microencapsulated with maltodextrins, AppleMetS). Results are expressed in line graph as the 
percentage of cell survival index to untreated control cultures and are reported as mean – SEM (n = 
5) of three independent experiments. Cisplatin is the positive control for cytotoxicity (cDDP). The 
amounts of cisplatin used to estimate its concentration/effect curve are reported as mg/mL (3 · 10-3 
, 7.5 · 10-3 , 1.5 · 10-2 ), corresponding to 10, 25, and 50 micromolar concentrations, respectively. 
***P < .001 versus control (untreated cells); **P < .01 versus control (untreated cells). (B) 
Inversely correlated fluorescent measures for live and dead cell counting after AMS treatments. 
HaCaT cells were incubated with AMS for the indicated times (24 and 48 h) and concentrations 
(from 0.009 to 2.3 mg/mL), and then the MultiTox-Fluor Multiplex Cytotoxicity Assay (Promega) 
was performed according to the manufacturer’s instructions. Results are reported in line graphs as 
mean percentage – SEM (n = 5) of live and dead cells of four independent experiments. cDDP, cis-
diamminedichloroplatinum; SEM, standard error of the mean 
 
 
 
Fig. 18: AMS effects on cell monolayers. Representative microphotographs at a 200 · 
magnification (20 · objective and a 10 · eyepiece) by phase-contrast light microscopy of human 
keratinocytes treated for the indicated times (24 and 48 h) with a range of concentrations (from 
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0.09 to 2.3 mg/mL) of AMS (Annurca apple polyphenolic extract microencapsulated with 
maltodextrins, AppleMetS). The shown images are representative of three independent 
experiments. IC50 concentrations of cisplatin (cDDP) are used as positive control for cytotoxicity. 
 
2.1.3.2 In vitro AMS supplementation strongly enhances keratin content in human skin 
cells 
To explore AMS effect on the regulation of keratin expression, HaCaT cells were cultured 
in standard growth medium in presence of tested concentrations of the extract (0.23 and 
0.46 mg/ml) for 24 and 48 h, as determined by preliminary bioscreens. After incubations, 
the total cellular levels of keratins were evaluated by Western blot analysis using a broad 
spectrum anti pan-keratin antibodies, as described in the experimental section. Cytokeratin 
bands identification was achieved  by molecular weight markers position (MW). As clearly 
shown, in vitro treatments for 48 h resulted in a remarkable increase of keratins expression, 
and this also occurs with a similar extent using a serum-free culture medium to exclude 
unspecific stimuli (see Fig. 19). The cellular content of cytokeratins was clearly enhanced 
in all the examined conditions, reaching a notable maximum increase of about 3-fold with 
respect to untreated control cells following 48 h of exposure to extracts at 0.46 mg/ml. This 
effect was concentration- and time-dependent (see Fig. 20), definitely due to the presence 
of AMS, as further suggested by the concurrent analysis of GAPDH protein, herein used as 
housekeeping gene. Noteworthy, the high weight molecular cytokeratin isoforms - i.e. K1, 
K4, K5 and K6/K10 - visibly reached a very high expression level throughout treatments - 
an effect probably due to induction of protein synthesis coupled to protein accumulation. 
Accordingly, we can assume that, without affecting cell growth and proliferation, the AFA 
extract supplementation is able to induce a remarkable increase in keratins levels in human 
skin cells, under many experimental conditions and even at both relatively low 
concentration (<0.5 mg/ml) and short exposure times (24 h). 
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Fig. 19: Concentration-dependent effects of AMS on keratin expression in HaCaT cells. (A) 
Western blot analysis showing the keratin levels in HaCaT cells exposed to AMS (Annurca apple 
polyphenolic extract microencapsulated with maltodextrins, AppleMetS) (0.23 and 0.46 mg/mL) 
for 48 h, in the presence (left lanes) or absence of serum (right lanes), as indicated in figure. Equal 
amounts of proteins (70 lg) were separated on a 10% SDS–polyacrylamide gel and subjected to 
Western blot analysis using monoclonal anti-pan-cytokeratin antibodies that recognize human 
AU16 c cytokeratins ranging from 68 to 40 kDa, as reported in the Experimental section. Shown 
are blots representative of three independent experiments. (B) After chemiluminescence, the 
keratin bands within each lane were quantified by densitometric analysis and plotted in line graph 
as percentage of control. The anti-GAPDH antibody was used to standardize the amounts of 
proteins in each lane. Shown are the averages – SEM values of three independent experiments. 
***P < .001 versus control (untreated cells). 
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Fig. 20: Time course effects of AMS on keratin expression in HaCaT cells. (A) Western blot 
analysis for the evaluation of the keratin total content in HaCaT cells exposed for 24 and 48 h to 
0.46 mg/mL of AMS (Annurca apple polyphenolic extract microencapsulated with maltodextrins, 
AppleMetS), in the presence (left blot) or absence (right blot) of serum. Equal amounts of proteins 
(70 lg) were separated on a 10% SDS–polyacrylamide gel and subjected to Western blot analysis 
using monoclonal anti-pan-cytokeratin antibodies that recognize the following human cytokeratins 
according to their molecular weight: K1 (68 kDa), K4 (59 kDa), K5 (58 kDa), K6/K10 (56 kDa), 
K13 (54 kDa), K8 (52 kDa), K18 (45 kDa), and K19 (40 kDa). Shown are blots representative of 
three independent experiments. (B) The cytokeratin bands within each lane were quantified by 
densitometric analysis and plotted in line graph as percentage of control. The anti-GAPDH 
antibody was used to standardize the amounts of proteins in each lane. Shown are the averages – 
SEM values of three independent experiments. ***P < .001 versus control (untreated cells). 
 
 
2.1.3.3 Enrolment and subject attrition 
Patients were enrolled in November 2015. A total of 340 patients were screened for 
eligibility; 90 patients (26.5%) did not pass the screening stage; 250 patients were 
randomised. The most common reason was that patients did not meet the inclusion criteria 
at baseline (n=38), followed by general refusal to participate for no specific reasons 
(n=14), and concerns about the protocol, especially fear of placebo (n=4). Some fulfilled 
exclusion criteria (n=34). 
Overall, 250 patients were assigned to the group assuming the two supplements: they were 
divided into two subgroups (each one made of 125 patients), according to the two different 
supplements chosen for this study. Patients of both subgroups underwent a placebo period 
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during the first 4 weeks before the treatment period of 8 weeks. Follow-up period lasted 
other 4 weeks. Figure 21 shows the flow of participants through the trials together with the 
completeness of diary information over the entire treatment period.  
No patient prematurely terminated study participation before allocation to treatment. 
Figure 21 follows the CONSORT PRO reporting guideline34 and reveals that within the 
assessment period, the following percentage of patients for each subgroup provided data 
for the primary endpoint: subgroup AMS, 74.6% (85 of 114 patients); subgroup AMSbzs, 
73.4% (83 of 113 patients). In each subgroup, a few patients did not submit any diaries, 
giving no specific reason for this. Completeness of the patient diaries did not differ 
between the treatment groups. 
 
 
 
Fig. 21: Study flowchart according to the consolidated standards of reporting trials (CONSORT). 
The diagram shows enrollment and primary efficacy endpoints based on patient diaries, from 
prescreening to data collection; and the extent of exclusions, loss to follow-up, and completeness of 
diary documentation available across the entire trial period. AMS, Annurca apple polyphenolic 
55 
 
extract microencapsulated with maltodextrins (AppleMetS); AMSbzs, formulation including 
Annurca apple polyphenolic extract microencapsulated with maltodextrins, biotin, selenium, and 
zinc (AppleMetS Hair); FAS, full analysis set 
 
 
2.1.3.4 Participants’ baseline characteristics 
Table 4 shows the demographic and clinical characteristics assessed at the baseline visit of 
all 250 patients randomised. Interestingly, more than half of the randomised patients were 
female; the total age range was 30-83 years. The groups were well balanced. 
 
 
                                                                                                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Baseline characteristics of intention to treat 
sample according to study treatment. 
Placebo 
Characteristics AMS (n=125) AMSbzs (n=125) 
Demographics   
Age (years) 42.4 ± 10.6 41.8 ± 10.8 
Male sex (No (%)) 58 (46.4%) 58 (46.4%) 
White ethnicity (No (%)) 125 (100%) 125 (100%) 
Clinical parameters   
Hair number/cm2 16.4 ± 4.6 15.7 ± 4.8 
Hair weight (mg)* 30.1 ± 8.1 29.6 ± 7.9 
Keratin content (mg)** 27.4 ± 6.4 26.9 ± 5.9 
Treatment 
Characteristics AMS (n=114) AMSbzs (n=113) 
Demographics   
Age (years) 43.5 ± 10.2 42.1 ± 11.1 
Male sex (No (%)) 51 (44.7%) 50 (44.2%) 
White ethnicity (No (%)) 114 (100%) 113 (100%) 
Hair number/cm2 15.9 ± 4.8 15.3 ± 4.5 
Hair weight (mg)* 29.9 ± 7.8 30.1 ± 8.0 
Keratin content (mg)** 27.2 ± 5.5 27.4 ± 6.1 
Value are means ± SD. 
AMS: Annurca apple polyphenolic extract microencapsulated with maltodextrins 
(AppleMetS);  AMSbzs: formulation including Annurca apple polyphenolic extract 
microencapsulated with maltodextrins, biotin, selenium, and zinc (AppleMetS Hair). 
* The weight is referred to an aliquot of 100 hairs (1 cm long). 
** The keratin content is referred to  an aliquot of 100 hairs (1 cm long). 
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2.1.3.5 Primary and secondary efficacy outcome measures  
No significant variation of hair number, weight, and keratin content with respect to the 
baseline values was registered at the end of placebo period in subjects belonging to both 
supplement-supplied groups (Table 5). Analyzing results, we can assert that the 
administration of both supplements led to a statistically significant variation of all of the 
clinical parameters. Specifically, AMSbzs supplement exerted the most important effects, 
increasing the hair number/cm2 by 125.2% (95% CI: -2.54, P = 0.0095), the hair weight by 
42.1% (95% CI: -3.41, P = 0.0019), and the keratin content by 40.1% (95% CI: -1.22, P = 
0.0042), at the end of the trial period (Table 5) (Fig. 22). Noteworthy, very significant 
results were achieved already after one month of intervention study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Effects of Annurca apple supplements on clinical parameters. 
 
  AMS Δ (%) AMSbzs Δ (%) 
Hair number/cm
2 
t 0 16.4 ± 4.6  15.7 ± 4.8  
t 30 25.3 ± 4.8 +54.3 25.1 ± 4.4 +60.1 
t 60 35.8 ± 5.1 +118.3 35.3 ± 5.7 +125.2 
Hair weight (mg)* 
t 0 30.1 ± 8.1  29.6 ± 7.9  
t 30 36.1 ± 7.6 +20.1 37.2 ± 6.8 +25.7 
t 60 41.3 ± 8.5 +37.3 42.1 ± 7.9 +42.1 
Keratin content (mg)** 
t 0 27.4 ± 6.4  26.9 ± 5.9  
t 30 32.4 ± 7.0 +18.4 33.2 ± 7.1 +23.5 
t 60 37.2 ± 6.9 +35.7 37.7 ± 6.7 +40.1 
Value are means ± SD (n = 5). 
AMS: Annurca apple polyphenolic extract microencapsulated with maltodextrins 
(AppleMetS); 
AMSbzs: formulation including Annurca apple polyphenolic extract microencapsulated with 
maltodextrins, 
biotin, selenium, and zinc (AppleMetS Hair). 
Subjects were administered with 2 AMS or AMSbzs capsules/day for 2 months. 
Results were significantly different at a level of P = 0.001. 
* The weight is referred to an aliquot of 100 hairs (1 cm long). 
** The keratin content is referred to  an aliquot of 100 hairs (1 cm long). 
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2.1.3.6 Safety issues 
All the laboratory analysis concerning the hepatic and renal function indicated no alteration 
of values after two months of AMS treatment (Table 6). Other safety assessments, such as 
vital signs, blood pressure, or electrocardiographic findings, were all periodically 
monitored and baseline values did not change substantially during and at the end of the 
trial.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.  Effects of Annurca apple supplements on plasma indicators of hepatic and renal 
function in subgroups. 
AMS 
 
AST (GOT)  
(U/L) 
ALT (GPT)  
(U/L) 
γ-GTP  
(U/L) 
ALP  
(U/L) 
 
t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 21.6 21.5 21.5 27.9 27.5 27.6 37.2 36.2 34.4 222.6 220.4 215.9 
Δ (%) 
 
-0.5 -0.5 
 
-1.4 -1.1 
 
-2.7 -7.5 
 
-0.98 -3.0 
 
LDH  
(U/L) 
Albumin  
(g/dL) 
Total bilirubin  
(mg/dL) 
Creatinine  
(mg/dL) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 177.0 176.5 170.2 4.31 4.32 4.16 0.57 0.57 0.54 0.84 0.82 0.80 
Δ (%)  -0.28 -3.84  +0.23 -3.48  - -5.26  -2.38 -4,76 
AMSbzs 
 
AST (GOT)  
(U/L) 
ALT (GPT)  
(U/L) 
γ-GTP  
(U/L) 
ALP  
(U/L) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 21.8 21.8 21.7 27.3 26.9 27.0 37.4 35.7 34.8 222.8 220.6 214.7 
Δ (%)  - -0.46  -1.46 -1.10  -4.54 -6.95  -0.99 -3.63 
 
LDH  
(U/L) 
Albumin  
(g/dL) 
Total bilirubin  
(mg/dL) 
Creatinine  
(mg/dL) 
 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 t 0 t 30 t 60 
Mean value 179.9 178.8 172.2 4.41 4.32 4.23 0.59 0.57 0.54 0.83 0.80 0.79 
Δ (%)  -0.28 -3.84  +0.23 -3.48  - -5.26  -2.38 -4,76 
Value are means ± SD (n = 5). 
AMS: Annurca apple polyphenolic extract microencapsulated with maltodextrins (AppleMetS);  AMSbzs: 
formulation including Annurca apple polyphenolic extract microencapsulated with maltodextrins, biotin, 
selenium, and zinc (AppleMetS Hair). 
Subjects were administered with 2 AMS or AMSbzs capsules/day for 2 months. 
Results were significantly different at a level of P = 0.001. 
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2.1.3.7 Study strength and limitations 
The major strengths of the clinical trial herein presented reside in the originality of the 
study and in the evaluation of the treatment effects in real-world settings. The positive 
results, herein reported, can inform physicians about a novel treatment/intervention, which 
can represent a valuable alternative in the clinical practice. It has also been reported that 
the anagen ratio undergoes seasonal changes: it rises to a maximum in March and falls to a 
minimum in September (Randall et al., 1991).  
Our clinical test was performed from January to July, so the effects of seasonal changes are 
unlikely to have influenced the overall results. Conversely, the main limitations of our 
study include the short-term assessment for the treatment of a chronic condition and the 
choice of exclusively white race. 
 
 
2.1.4 Discussion 
Polyphenols have always been important antioxidants of the human diet (Ferreira et al., 
2002; Cos et al., 2004 and Fu et al., 2015). Among them, oligomeric procyanidins have 
also shown remarkable hair growth stimulant effects in vitro and in vivo, being able to 
promote hair epithelial cell growth and anagen induction of the hair cycle (Kamimura et 
al., 2006). In particular, procyanidins B2 and B3 show evidence of protective actions 
versus apoptosis in hair epithelial cell cultures, thereby restricting catagen induction in the 
hair cycle (Kamimura et al., 2006). Analysing results (Table 5), we found that, on average, 
after two months, hair growth, weight, and keratin content, increased by 118.3, 37.3 and 
35.7%, respectively. Surprisingly, the co-formulation named as AppleMetS Hair 
(AMSbzs), obtained by adding to the AMS supplement the vitamin biotin, and the minerals 
zinc and selenium, three elements well known for their positive general effects on hair and 
skin (Reg. EU n. 1924/2006), led the second subgroup of subjects to only slightly higher 
results in terms of hair growth, weight, and keratin content (Table 5), clearly indicating for 
AMS a major role in promoting hair growth and tropism. In spite of the small number of 
subjects and the short period over which the trial was carried out, we observed a clear trend 
and significant results for both supplements in each subgroup, which were revealed by 
some statistical analyses towards increased hair growth and density (Table 5). 
Some clinical trials have extensively demonstrated the positive hair-growing effects of 
procyanidin B2, a major dimeric procyanidin occurring in apples (Kamimura et al., 2000; 
2002 and  Takahashi et al., 2001). Actually, these studies have exclusively investigated the 
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potential benefits of topical applications of procyanidin B2 under the form of alcoholic 
solutions in mixture with other bioactive components. Kamimura et al. (2000) have 
reported the effects of 1% procyanidin B2 tonic on human hair growth after sequential use 
for 6 months. A double-blind clinical test involving a total of 29 male subjects was 
performed. It was observed an increase of 6.7 total hairs/0.25 cm2 after 6 months of 
procyanidin therapy. The same effects have been reported with minoxidil (Kreindler et al., 
1987, Roberts et al., 1987 and Savin et al., 1987) and finasteride (an inhibitor of type II 5α-
reductase, Merck)(Kaufman et al., 1998) therapy for androgenetic alopecia. In 2% 
minoxidil treatment, an increase of 250 total hairs/5.1 cm
2
 (calculated as 12.3 total 
hairs/0.25 cm2) after 12 month therapy was reported (Kreindler et al. 1987). In finasteride 
treatment (1 mg/day, oral administration), an increase of 86 total hairs/5.1 cm2 (calculated 
as 4.22 total hairs/0.25 cm2) after 12 month therapy was reported (Kaufman et al., 1998). 
The level of efficacy of 1% procyanidin B2 is concluded to compare favourably with 
minoxidil and finasteride therapy (Kamimura et al., 2000). As far as the procyanidins are 
concerned, it has been demonstrated that in murine epithelial cells both procyanidins B2 
and B3 are capable of increase the anagen growth phase within hair cycle by means of their 
protective action on cellular apoptosis induced by the androgen-inducible cytokine 
Transforming Growth Factor (TGF) β1 and β2, which normally cause a cell cycle block in 
favor of differentiation processes and are thereby supposed to trigger catagen induction in 
hair follicle (Hibino et al., 2004). In the same way, procyanidins exhibited intensive 
biological effects in promoting hair epithelial cell growth in murine models in vivo, leading 
to increased hair density and terminal hair formation (Kamimura et al., 2006). Indeed, the 
addition of TGF-β1 or TGF-β2 to cultured murine hair epithelial cells dose-dependently 
decreased cell growth by increasing apoptosis via intrinsic caspase network, whereas the 
concurrently addition of procyanidin B2 to the culture medium counteracted both TGF-β1 
and TGF-β2 effects, protecting cells from apoptotic pathways activation. Interestingly, 
Kamimura et al. (2006) also showed that procyanidin B2 upregulates the expression of 
MAPK/ERK Kinase (MEK-1/2) in the hair epithelial cells, as well as their activation 
(Kamimura et al., 2006). MEK is a member of the MAPK signaling cascade that is 
generally activated by mitogens, so that when MEK is inhibited, cell proliferation is 
blocked and apoptosis is induced (Wellbrock et al., 2016). Not surprisingly, components of 
the MAPK/ERK pathway were mainly discovered in cancer cells (Santarpia et al., 2012) in 
which drugs able to reverse the "on" or "off" switch are currently being investigated as 
cancer chemotherapeutics (Asati et al., 2016, and Ruscono et al., 2012). However, it is still 
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unclear whether these two suggestions are correlated, and especially if procyanidins are 
able to interact with distinct cell membrane receptors involved in MAPK/ERK signalling 
pathways and/or to directly interfere with this cascade of intracellular proteins.    
During hair growth and proliferation, several cytokeratins expressed by epithelial cells 
orchestrate the assembly of typical intermediate filaments, which contribute in common 
with keratin-associated proteins (KAPs) in the production of the hair shaft within the 
keratinisation process of the hair fiber (Makar et al., 2007). All the well-known 54 human 
keratins belonging to the IF proteins share common structural and functional features. In 
addition, evidently bundled as tonofilaments in epidermal tissue, keratin filaments are 
endowed with key functional role in the integrity and mechanical stability of both the 
single epithelial and hair cells and, via cell contacts, of the whole epithelial tissue 
(Schweizer et al., 2006). As well, the central function of epidermis-type keratins is 
demonstrated by knock-out mouse models but also throughout different human hereditary 
keratin diseases affecting skin and hair (Moll et al., 2008). Therefore, since keratins are 
fundamental in epidermal and hair development and homeostasis, the regulation of keratins 
expression appears to be a central event for rapid proliferating epidermal cells, as well as in 
hair follicle growth and maturation. To date, despite the use of dietary nutraceutics and 
functional food supplements has greatly increased, studies concerning their biological 
effects on hair loss have produced conflicting results (Miniaci et al., 2016). Conversely, by 
targeted bioscreen we have herein demonstrated that AMS supplementation in vitro is able 
to promote a remarkable up-regulation of keratin expression in human keratinocytes, 
resulting in keratins accumulation within cells. These data are fully consistent with those 
arising from our clinical trial - which indicates an important increase of the keratin hair 
content, of about 35% more than in untreated group - thereby validating the biological 
effects of AMS on hair growing and proliferation. To the best of our knowledge, no 
correlation between the administration of nutraceuticals and actual increased expression of 
keratin in human skin cells had been reported so far. As well, this is the first study 
demonstrating the effectiveness of a natural procyanidin B2-containing gastro-protected 
apple extract as hair growth-stimulant via oral administration. For these reasons, we 
believe that the reported findings concerning the use of AMS as oral nutraceutical 
supplement are of great interest, as they reveal an efficacy in promoting hair growth fully 
comparable with or even higher than those obtained from trials performed with 
pharmaceutical therapies nowadays regarded as the leading treatments for the pattern 
baldness. In addition, our proposed therapy, apart not giving any sign of hirsutism in all of 
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the enrolled subjects, would allow to avoid the possible inconvenience deriving from the 
topical application of a generic alcoholic solution (skin burning, reddening, and cracking), 
or, more importantly, specific side effects, which are typical of finasteride, such as sexual 
dysfunctions (Venkataram et al., 2014) or of minoxidil, such as cardiovascular (Pettinger et 
al., 1980; Reichgott et al., 1981; Krehlik et al., 1985) immunologic (Tunkel  et al., 1987; 
Mitas et al.,1981) and endocrine disorders (Nguyen et al., 2009).In fact, no evidences of 
cytotoxic effect nor morphological changes on cultured human keratinocytes were hitherto 
observed after exposure to AMS under different experimental conditions. Similarly, with 
the exception of antiproliferative effects on cancer cells and antibacterial activities, any 
type of cytotoxicity induced by apple bioactive components has never been reported in 
scientific literature (Schiavano et al., 2015; Sudan et al., 2014; Hyson et al., 2009 and Luo 
et al., 2016) 
 
Fig. 22:Some examples of subjects (1,2,3 male and 4 female),who have consumed 2capsules/day 
of AMSbz supplement for 60 days (T0 and T60) 
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2.1.5 Conclusion 
Male and female pattern baldness is a highly common condition affecting approximately 
50% of the adult population, and potentially causing a significant negative impact on the 
quality of life. The results of this clinical trial, in combination with in vitro evidence of 
increased cellular keratin content, provide strong support that a dietary supplement acting 
as nutraceutical and based on a procyanidin B2-containing AFA natural extract can 
effectively promote hair growth and improve skin quality, at once increasing hair density, 
weight, and keratin content. Further studies are ongoing to better clarify the molecular 
basis of the procyanidins-induced growth promotional effects at the skin level, focusing 
both on the regulation of cells homeostasis and on the functional role played by keratins 
selectively induced via nutraceutical supplementation. 
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Chapter 2 
 
Nutraceutical Formulations 
2.2 Protection from gastrointestinal digestion is required to preserve the WNT inhibitory 
activity exerted by apple extracts on colon-rectal cells carrying FAP mutations 
 
 
2.2.1 Introduction 
Familial adenomatous polyposis (FAP) is an inherited colorectal cancer syndrome 
characterized by the formation of a large number of adenomas throughout the large bowel. 
The birth frequency of FAP in European populations is estimated at roughly 1 in 20,000 
live births and progression to colorectal cancer  is very  high probably in the age of 35–40 
yr (Galiastatos et al., 2006). While colectomy remains the optimal prophylactic treatment, 
the identification of chemopreventive agents represents one of the major challenges for the 
future (Galiastatos et al., 2006). 
FAP is caused by a germline mutation in the adenomatous polyposis coli (APC) gene on 
chromosome 5q21. This locus contains a tumor suppressor gene encoding for the protein 
APC, that functions intracellularly as scaffold in the large protein complex known as “ β-
catenin destruction complex”. This includes the serine/threonine kinase Glycogen synthase 
kinase-3 β, Axin, and Casein Kinase I. The complex represents an important intracellular 
check point since it reduces the intracellular levels of β-catenin by targeting it to 
proteasomal degradation. Its activity avoids translocation of β-catenin into the nucleus and 
its binding to the transcription factors TCF and LEF, both promoting the expression of 
mitogenic genes c-myc and cyclinD1(Clevers et al., 2012; Dijksterhvis et al., 2014; Miki et 
al., 2011 and Krousova et al., 2014). 
Wild Type APC counterbalances the activity of the WNT (Wingless-related integration 
site) pathway, a signaling cascade regulating development in embryos and tissue 
homeostasis in adult organs (Clevers et al., 2012). In the gastrointestinal (GI) tract, WNT 
supports the self-renewal capacity of epithelial stem cells allowing GI organs to be the 
most intensively self replenishing in mammals. (Burges et al. 2011). The Frizzled (FZD) 
GPCRs’ family members act as WNT receptors and, upon activation, recruit and 
disassemble the β-catenin destruction complex inhibiting its function and causing β-catenin 
intracellular accumulation and nuclear translocation. This is the reason for why FAP 
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mutations, by abolishing APC function, lead to constitutively active WNT signaling and in 
turn to uncontrolled proliferation of colon cells, formation of polyps and adenocarcinomas. 
Apple extracts have been shown to mediate several biological cellular effects that might be 
of interest with respect to chemoprevention of colorectal diseases. Such activity mostly 
relies on the high amount of polyphenols they contain (Kernet al., 2006). Polyphenol-rich 
apple extracts have been shown to suppress human colon cancer cell growth in several in 
vitro culture models. Moreover, in a murine model of FAP, the APC
Min/+
 mice, the 
assumption by beverage of apple polyphenol extracts affected number and growth of colon 
polyps, reduced colorectal bleeding and high-grade dysplasia (Fini et al., 2011). The action 
of the apple polyphenols has been so far mainly ascribed to their antioxidant potential. 
However, new researches have recently shown several polyphenols being endowed of 
inhibitory activity toward specific protein targets, among the others, many of the 
components WNT signaling pathway (Ishibeshi et al., 2015). 
The aim of this part of my thesis work was to test the WNT inhibitory activity of two apple 
cultivars native to Southern Italy, namely “Annurca” and “Limoncella”, identify the 
polyphenols mainly responsible for their inhibitory activity and their mechanism of action.  
Malus pumila Miller cv. Annurca is a widespread apple and accounts for the 5% of 
national apple production. It is listed as Protected Geographical Indication (PGI) product 
from the European Council [Commission Regulation (EC) No. 417/2006)]. This apple has 
been already shown to posses nutraceutical potential in virtue of its ability to reduce 
cellular glucose levels and lipid uptake (Tenore et al., 2013;2014;2016 and Sommella et al. 
2015).  Malus domestica cv ‘Limoncella’ is a juicy and aromatic variety of apple known 
since ancient roman times (D’Ambrosca et al., 2007). It resists to long time storage and 
survive to cold winters. Differently from Annurca, Limoncella’s nutraceutical potential has 
not yet been fully documented. 
I tested on in vitro cultures of cells carrying FAP mutations and on ex vivo biopsies of 
FAP patients, the WNT inhibitory activity of “Annurca” and “Limoncella” apple extracts, 
identified the mechanism underpinning their activity and evaluate their potency upon in 
vitro simulated gastrointestinal digestion. 
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2.2.2 Materials and methods 
2.2.2.1 Reagents  
Salt and organic solvents were from Applichem (Darmstadt, Germany) and Sigma-Aldrich 
(St. Louis, MO, USA). Polyethylenimina (PEI, #408727, Sigma-Aldrich); Lipofectamine 
2000 (#11660-019, Invitrogen, Thermo Fisher Scientific, MA, USA).  
Cell Cultures - HEK293, CaCo-2, and U87MG cells were grown in DMEM (#41965-039, 
GIBCO, Thermo Fisher Scientific) supplemented with 10% FBS (#10270, GIBCO), 
Glutamax (#35050-061, GIBCO) and Pen/Strep (#15070-063, GIBCO). HEK293 
transfection was performed using PEI (Generoso et al. 2015). CaCo-2 transfection was 
performed using Lipofectamine (Invitrogen) following manufacturer instruction. Cell 
viability was measured with the Trypan Blue and Propridium Iodide. Percentage of cells in 
apoptosis was measured with mitotracker red (Life Technologies) following manufacturer 
instructions.  
 
2.2.2.2 Excision and culturing of human biopsies from FAP patients 
Biopsies from Familial Adenomatosis Poliposis patients were kindly provided by Prof. G. 
B. Rossi. The study was approved by the Ethic Committee of the Istituto Nazionale Tumori 
"Fondazione G. Pascale", IRCCS, Napoli, Italy and of the University Federico II of 
Naples. Immediately after excision, biopsies were rinsed in physiological saline. Samples 
were then digested with Trypsin for 10 min at RT and centrifuged at 400 rpm for 10 min at 
RT. Isolated cells present in the supernatant were then counted and cultured at the 
confluency of 100,000 cell per ml in DMEM supplemented with 10 % FBS, Glutamax and  
Pen/Strep. When indicated Limoncella extract was added at the concentration of 400mg/l. 
After 24 and 48 hours of incubation, cell viability was measured with the Trypan Blue 
assay and Propridium Iodide.  
 
2.2.2.3 DNA 
All DNA constructs were synthesized at GeneScript (USA). The cDNA coding for N 
terminally HA tagged FZD4wt (HA-FZD4-wt), was cloned in the expression vector  
pCDNA3.1 (Invitrogen). For the reporter construct WNT reporter GFP construct: 8 repeats 
of the optimized TCF/LEF binding sequence [5’-AGATCAAAGGGG-3’] (interspaced by 
the triplet 5’-GTA-3’) were positioned upstream to a minimal TATA box promoter [5’-
tagagggtatataatggaagctcgaattccag-3’] and a KOZAC region [5’-
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cttggcattccggtactgttggtaaaaagcttggcattccggtactgttggtaaagccacc-3’]. The sequence was 
cloned in the vector pCDNA 3.1 (+) GFP between the restriction sites for NruI and 
HindIII. This replacement substitutes the CMV promoter of the original vector with the 
TCF/LEF responsive sequences. Correctness of the sequences were verified by DNA 
sequencing.  
 
2.2.2.4 WNT pathway activity measurement using the TCF-GFP constructs   
HEK293 cells were seeded (5 x 10
3
 per well) in  96-well black Optyplates (Perkin Elmer). 
After 24 hours, cells were co-transfected with both WNT reporter GFP construct and HA-
FZD4-wt. Transfection mixtures were prepared as follow: for each well 0,25µg of PEI (pH 
7.0) was supplemented with  0,08 µg of DNA( both diluted in 4 μl of DMEM). The 
mixture was incubated at room temperature for 30 min to be then diluted in culture 
medium and added to the cells. 24 hours after transfection, medium was replaced and cells 
incubated with WNT5A conditioned medium. Human glyoblastoma U87MG cells were 
used as source of WNT5A conditioned medium. 16 Confluent 6 cm plates of U87MG cells 
were incubated for 3 days in DMEM, 10% FBS and Glutamax in the absence of 
antibiotics. Conditioned medium was thus collected and stored at  -20°C. Cells were then 
rinsed with fresh medium and cultivated for a further period of 3 days. The conditioned 
medium obtained after the second incubation was pooled with the first one. The pooled 
conditioned medium was used to stimulated TCF/LEF activity in HEK293 cells. It was 
used undiluted (EC100). When indicate conditioned medium was supplemented with the 
indicated compounds or apple extracts at the indicate concentration. After 48 hours cells 
were fixed in 3.7% formaldehyde in PBS pH 7.4 for 30 min. Formaldehyde was quenched 
by incubating the cells for 30 min in 0.1 M Glycine in PBS 1X. The activity of the 
compounds was evaluated by measuring GFP expression.  
 
2.2.2.5 WNT Pathway Activity Measurement in CaCo-2 Cells Using the TCF-GFP 
Constructs  
CaCo-2 cells, growing on glass coverslips, were transfected by Lipofectamine , according 
to the to the manufacturer’s procedures. Twenty-four hours after transfection, the medium 
was replaced and cells were incubated with the indicated extracts for 24–48 h. The cells 
were then fixed in a solution of 3.7% formaldehyde, in PBS with a pH 7.4, for 30 min. 
Formaldehyde was quenched by incubating the cells for 30 min in 0.1 M glycine in PBS. 
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2.2.2.6 Immunofluorescence 
CaCo-2 cells were grown on glass coverslips. Cells were fixed in 3.7% formaldehyde/PBS 
(pH 7.4) for 30 min. Formaldehyde was quenched by incubating the cells for 30 min in 0.1 
M glycine in PBS 1x. Then, cells were permeabilized in 0.1% Triton/PBS, pH 7.4, for 10 
min at 25 ◦C and then incubated with a rabbit polyclonal anti-β-catenin antibody (H-102, 
sc-7199, Santa Cruz, Dallas, TX, USA) diluted 1:200 in PBS and a goat anti-rabbit IgG 
(H&L), DyLight 594 conjugate, (ImmunoReagents, Raleigh, NC, USA) (diluted 1:500 in 
PBS), for 1 h and 45 min, respectively. 
 
2.2.2.7 Fruit Collection and Sample Preparation  
Annurca (Malus Pumila Miller cv Annurca) apple fruits and Limoncella (Malus Domestica 
cv Limoncella) were collected from Valle di Maddaloni (Caserta, Italy), in October 2016, 
when fruits had just been harvested. Annurca fruits were reddened for about 30 days, and 
then analyzed ( Lo Scalzo et al.,2001). Lyophilised peels and flesh (10 g) of Limoncella 
and Annurca apple samples were treated with 60 mL of 80% methanol (0.5% formic acid), 
homogenized for 5 min by ultra-turrax (T25-digital, IKA, Staufen im Breisgau, Berlin, 
Germany) and shaken on an orbital shaker (Sko-DXL, Argolab, Carpy, Italy) at 300 rpm 
for 15 min. Then, the samples were placed in an ultrasonic bath for another 10 min, before 
being centrifuged at 6000 rpm for 10 min. The supernatants were collected and stored in 
darkness, at 4 ◦C. The pellets obtained were re-extracted, as described above and with 
another 40 mL of the same mixture of solvents. Finally, the extracts obtained were filtered 
under vacuum, the methanol fraction was eliminated by evaporation, and the water fraction 
was lyophilized. To obtain polyphenol-enriched fractions of Annurca apple extract (AAE) 
and Limoncella apple extract (LAE) (in the text referred to as PEF(AAE) and PEF(LAE), 
respectively) the dry extracts were dissolved in distilled water and slowly filtered through 
an Amberlite XAD-2 column, packed as follows: Resin (10 g; pore size 9 nm with particle 
sizes of 0.3–1.2 mm; Supelco, Bellefonte, PA, USA) was soaked in methanol, stirred for 
10 min and then packed into a glass column (10 × 2 cm). The column was washed with 
100 mL of acidified water (pH 2) and 50 mL of deionized water for removal of sugars and 
other polar compounds. The adsorbed phenolic compounds were extracted from the resin 
by elution with 100 mL of methanol, which was evaporated by flushing with nitrogen. The 
extracts were stored at −80 ◦C until HPLC analysis. Before performing the biological tests, 
each extract was dissolved in DMSO at a final concentration of 300 mg/mL. Food grade 
Limoncella apple extracts (IndLAE) were produced at MB-Med (Turin, Italy) starting from 
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fresh Limoncella Apples. Upon lyophilization of peels and flesh of Limoncella apples, 
samples were treated with ethanol/water (70:30 v/v) for 24 h at 40 ◦C to extract phenolic 
compounds and generate food grade Limoncella Apple Extracts (in the text referred to as 
IndLAE). 
 
2.2.2.8 HPLC-DAD
 
analysis 
Extracts from the three different apple varieties and of industrial products were solubilized 
with 1% formic acid. Analyses were run on a Jasco Extrema LC-4000 system (Jasco Inc., 
Easton, MD) provided with photodiode array detector (DAD). The column selected was a 
Kinetex
®
 C18 column (250 mm × 4.6 mm, 5 μm; Phenomenex, Torrance, CA). The 
analyses were performed at a flow rate of 1 mL/min, with solvent A (2% acetic acid) and 
solvent B (0.5% acetic acid in acetonitrile and water 50:50, v/v). After a 5 min hold at 10% 
solvent B, elution was performed according to the following conditions: from 10% (B) to 
55% (B) in 50 min and to 95% (B) in 10 min, followed by 5 min of maintenance. 
Flavonols, procyanidins, dihydrochalcones, flavanols and hydroxycinnamic acids were 
monitored at 280 nm and anthocyanins at 520 nm. For quantitative analysis, standard 
curves for each polyphenol standard were prepared over a concentration range of 0.1-1.0 
μg/μL with six different concentration levels and duplicate injections at each level. The 
identity of polyphenols was confirmed by comparison to those of commercial standards. 
 
 
2.2.2.9 In vitro gastrointestinal digestion 
In vitro gastrointestinal digestion was performed according to a procedure described 
previously (Raiola et al., 2012), with slight modification. In vitro gastrointestinal digestion 
was distinguished into different steps: salivary, gastric and duodenal digestive steps. For 
the salivary digestion, apple samples (20 g) were mixed with 6 mL of artificial saliva 
consisting of: potassium chloride (KCl, 89.6 g/L), potassium thiocyanate (KSCN, 20 g/L), 
monosodium phosphate (NaH2PO4, 88.8 g/L), sodium sulphate (Na2SO4, 57.0 g/L), sodium 
chloride (NaCl, 175.3 g/L), sodium bicarbonate (NaHCO3, 84.7 g/L), urea (25.0 g/L) and 
α-amylase (290 mg). The pH of the solution was adjusted to 6.8 with HCl 0.1 N. Then, the 
mixture was introduced in a plastic bag containing 40 mL of water and homogenised in a 
Stomacher 80 Microbiomaster (Seward, Worthing, UK) for 3 min. Immediately, 0.5 g of 
pepsin (14800 U) dissolved in HCl 0.1 N was added, the pH was adjusted to 2.0 with HCl 
6 N, and then incubated at 37 °C in a Polymax 1040 orbital shaker (250 rpm) (Heidolph, 
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Schwabach, Germany) for 2 h. After the gastric digestion, the duodenal step was simulated 
as follows: the pH was increased to 6.5 with NaHCO3 0.5 N and then 5 mL of a mixture 
constituted by pancreatin (8.0 mg/mL) and bile salts (50.0 mg/mL) (1:1, v/v), dissolved in 
20 mL of water, was added and incubated at 37 °C in an orbital shaker (250 rpm) for 2 h. 
After each step of digestion, 10 mL of the obtained extract were centrifuged at 4000 rpm 
and 4 °C for 1 h: before each following step, the digestion procedure was started over 
again. To determine the polyphenolic profile, the supernatants were extracted with a 
mixture of acetonitrile-water (84:16; v/v) and then analysed by HPLC. 
 
2.2.2.10 Statistical Analysis  
 EC50 were calculated from dose-response data using nonlinear regression analysis of 
Prism software 6.0 (GraphPad, GraphPad Software, San Diego California USA, 
www.graphpad.com). All data were analyzed using the two-tailed Student’s t-test. Two 
way ANOVA test was used to compare columns. P < 0.05 were considered statistically 
significant. 
 
 
2.2.3 Results  
2.2.3.1HPLC-DAD analysis 
Total (flesh and peel) polyphenolic contents in Limoncella and Annurca apple extracts 
were determined by HPLC-DAD analysis and are reported in the following table : 
 
 AAE*  LAE* PEF(AAE)** PEF(LAE) ** 
Chlorogenic Acid 3.9 ±0.2 4.7 ±0.1 10.2 ±0.6 9.7 ±0.9 
[+] Catechin 0.8 ±0.1 1.3 ±0.1 3.0 ±0.2 5.5 ±0.4 
[-] Epicatechin 0.9 ±0.2 1.3 ±0.1 2.8 ±0.1 4.0 ±0.2 
Isoquercetin  1.4 ±0.1 2.9 ±0.2 3.4 ±0.3 2.7 ±0.3 
Rutin 11.2 ±0.2 0.4 ±0.3 34.7 ±0.1 1.7 ±0.2 
Phloridzin 2.1 ±0.3 1.2 ±0.5 7.5 ±0.2 3.0 ±0.1 
Procianidine B2 1.3 ±0.1 2.8 ±0.1 4.1 ±0.1 10.8 ±0.1 
Phloretin n.d. n.d. n.d. n.d. 
Quercetin  n.d. n.d. n.d. n.d. 
 
Table 7: Polyphenolic content present in: Annurca Apple Extract (AAE), Limoncella Apple 
Extract (LAE), a polyphenolic purified fraction of AAE (PEF(AAE)), a polyphenolic purified 
fraction of LAE ((PEF(LAE)). * mg/100g of DW; ** mg/100mg DW; n.d., non detected;  
Values are reported as mean ± s.d.(n=3); 
 
70 
 
AAE (Annurca apple extract) and LAE (Limoncella apple extract) present qualitatively 
similar polyphenolic repertoires. They contain similar amount of Chlorogenic acid, the 
most abundant hydroxycinnamic acid in apples as well as of the flavan-3-ols [+] Catechin 
and [-] Epicatechin. The Quercetin-glycosides, Rutin and the phloretin–glycoside, 
phloridzin are more abundant in AAE than in LAE, that on the contrary contains, as 
already reported, higher amounts of Procyanidine B2 and isoquercetin
 (D’Ambrosca et al., 
2007 and Sommella et al., 2015). The aglycones Quercetin and Phloretin are absent in both 
the extracts (Sommella et al., 2015). PEF(AAE) and PEF(LAE), were respectively, the 
purified extracts of Annurca and Limoncella, more rich , as shown in the table, in 
polyphenlic compounds. 
 
HPLC-DAD analysis of the flavonoid content of the IndLAE (Industrial Limoncella 
extract) did not reveal major change in the amount of polyphenols compared to AAE and 
LAE. However, I realized the presence of a discrete amount of Quercetin , which was 
absent in the correlative non industry extract. Probably this quantity of quercetin derives 
from the conversion of quercetin glycosides into their aglycone form, during the industrial 
production. In IndAAE is not reached this Quercetin concentration increase so high. (data 
not showed). 
 
 Ind(LAE)  
Chlorogenic Acid 8.6±0.1 
Catechin 1.4±0.2 
Epicatechin 0.7±0.1 
Isoquercetin  0.5±0.1 
Rutin 2.6±0.3 
Phoridzin 7.0±0.4 
Procianidine B2 2.5±0.1 
Quercetin  1.2±0.1 
Phloretin n.d. 
 
 
Table 8: Polyphenolic content of: Industrial Limoncella Extract (IndLAE) mg/100g DW;Values 
are reported as mean ± s.d.  
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2.2.3.2 In vitro digestion 
Results of HPLC-DAD analysis of the polyphenolic contents in digested AAE and LAE 
are reported in Table 9. As expected, in vitro digestion decreased the overall polyphenolic 
content of around 40-50%. For both cultivars, digestion converted procyanidins into 
monomeric catechins, and the amount of chlorogenic acid, rutin, epicatechin and 
isoquercetin was drastically reduced. Interestingly, GI digestion reduced the content of 
phloridzin in AAE but, not in LAE where the molecule almost completely resisted to GI.  
        
 digAAE* digLAE* 
Chlorogenic Acid 0.9 ±0.1 0.7 ±0.1 
[+]Catechin 2.5 ±0.1 2.8 ±0.1 
[-] Epicatechin 0.1 ±0.1 0.3 ±0.1 
Isoquercetin  0.1±0.1 0.1 ±0.1 
Rutin 0.3 ±0.2 n.d. 
Phloridzin n.d. 0.3 ±0.1 
Procianidine B2 n.d. 0.2 ±0.1 
Phloretin n.d. n.d. 
Quercetin  n.d. n.d. 
  
Table 9:Polyphenolic content of: in vitro digested Annurca Apple Extract (digAAE), in vitro 
digested Limoncella Apple Extract (digLAE); * mg/100g of DW. 
Values are reported as mean ± s.d. 
 
 
2.2.3.3 WNT pathway activity measurement using the TCF-GFP constructs   
The activity of the apple extracts on WNT/β-catenin signaling was assayed in a 
reconstituted recombinant system. I used, as a biological platform, human embryonic 
HEK293 cells, transiently expressing both the WNT receptor Frizzled 4 (FZD4) and a 
WNT pathway reporter DNA construct. Three different WNT reporter constructs were 
used. The first, hereinafter referred to as TCF-wt GFP, presents the coding sequence of 
GFP under the control of an optimized WNT pathway responsive promoter. In the second, 
hereinafter referred to as TCF-mut GFP, the WNT responsive promoter was mutagenized 
to become unresponsive to WNT. Finally, a third reporter construct (cmv GFP) presents 
the coding sequence of GFP under the control of a constitutive cmv promoter. The TCF-
mut GFP and cmv GFP constructs were here considered as negative controls, and used to 
monitor WNT unrelated change in GFP expression. Activation of canonical WNT pathway 
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upon treatment with the FZD4 agonist WNT-5A induces GFP expression and increases the 
fluorescence of the cells (Figure 23A).  
 
 
Fig. 23: AAE and LAE act as WNT pathway inhibitors mainly due to their polyphenolic content. (A). 
HEK293 cells were transfected with cDNA coding for the WNT reporter GFP construct and the WNT 
receptor FZD4. Activation of the pathway by WNT5A (a FZD4 agonist) induces expression of GFP. The 
histogram shows the increase in WNT pathway activity after treatment with WNT5A in the presence or in the 
absence of the WNT receptor FZD4 (B-C) Dose-response curves for AAE and LAE modulation of WNT/β-
catenin pathway in HEK293 cells co-expressing FZD4 and the WNT reporter construct. Values indicate 
changes in GFP expression ( expressed as percentage of change over untreated samples).(D-E) Dose-
response curves for PEF(AAE) and PEF(LAE) modulation of WNT/β-catenin pathway. In A values are 
reported as mean +/- s.e.m (n=5). ANOVA testing *** P<0.05. IN B-E values are reported as mean +/- s.d. 
(n=3). EC50 values for each sample are shown under the corresponding graph and are reported as mean +/- 
s.e.m (n=5). 
 
 
AAE and LAE both worked efficiently as WNT inhibitors and reduced WNT activity 
elicited by WNT5A. EC50 of WNT pathway inhibition were of 140 +/- 16 mg/L and 330 
+/- 23 mg/L for AAE and LAE, respectively (Figure 23B-C). The WNT inhibitory activity 
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of both the extracts mainly depends on their flavonoid content. AAE and LAE fractions 
enriched in polyphenols,  PEF(AAE) and PEF(LAE)) (Table7) presented WNT inhibitory 
potency increased compared to total fresh fruit extracts (2.1 +/- 0.3 mg/L and 4.1 +/- 0.2 
mg/L for PEF(AAE) and PEF(LAE), respectively) (Figure 23D-E). The WNT inhibitory 
activity of both full extracts and polyphenolic fractions cannot be ascribed to their toxicity 
on cells, that occurs at 10g/L (data not shown), a concentration higher than their EC50 of 
inhibition of the WNT pathway activity. 
I thus moved to identify which polyphenols were mostly contributing to WNT inhibitory 
activity of the apple extracts (Figure 24 and Table10). Pure Epicatechin and Catechin 
showed very weak inhibition of the WNT5A elicited TCF/LEF activity. Chlorogenic acid 
presented a WNT inhibithory activity of  3.4 ± 0.2 μM. Rutin and Isoquercetin presented 
EC50 of inhibition at 1.8 ± 0.1 μM and 3.1 ± 0.4 μM, respectively The dihydrochalcone 
Phloridzin presented EC50 at 12.9 ± 0.5 μM while Procianidine B2 of 1.4± 0.3 μM . 
Considering their low abundance in both the apple extract, none of the abovementioned 
molecules would reach WNT inhibitory effective concentrations in AAE and LAE 
solutions diluted at their EC50 (Table10). Thus, while polyphenols surely contribute to the 
WNT inhibitory activity of the apple extracts, none of the polyphenol by itself can account 
for the full activity of AAE and LAE, that seem to require, on the contrary, the presence of 
all the components of the polyphenolic fraction.   
 
 
 
a
 EC50(M)         
b
 M
  
Chlorogenic Acid 3.4 ± 0.2 x 10
-6
 ≈5.3 x 10-8 
Catechin 2.5 ± 0.3 x 10
-4
 ≈1.8 x 10-8 
Epicatechin >>  10
-4
 ≈2.6 x 10-8 
Isoquercetin  1.8 ± 0.1 x 10
-6
 ≈7.8 x 10-9 
Rutin 3.1 ± 0.4 x 10
-6
 ≈2.6 x 10-9 
Phoridzin 1.2 ± 0.2 x 10
-5
 ≈1.1 x 10-8 
Procianidine B2 1.4 ± 0.3 x 10
-6
 ≈1.9 x 10-8 
 
Table 10: b EC50 of WNT pathway inhibition of the indicated compounds. Values are reported as mean ± 
s.e.m (n=3)a Molarity of the indicated compounds in a solution of  LAE at its EC50 concentration.
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Fig. 24: WNT inhibitory activity of apple polyphenols. Dose-response curves for the indicated compounds 
modulation of WNT pathway in HEK293 cells. Values as reported as mean +/- s.d. (n=3). EC50 values for 
each compound are reported in Table10. 
I thus moved to identify the WNT pathway branches inhibited by AAE and LAE. This is 
very important especially when searching for therapeutic agents to use for FAP patients. 
Since APC is a midstream component of the WNT pathway, its mutations make 
manipulation of upstream components of the WNT pathway therapeutically ineffective. To 
be active in FAP patients, WNT inhibitors should act either downstream to APC or on 
“non canonical” WNT pathway branches. One of the most active non-canonical branches 
positively contributing to WNT signaling is the one involving the EGF Receptor (EGFR). 
Once activated, the EGFR pathway bypasses APC and leads, via AKT, to β-catenin 
activation. I thus challenged AAE and LAE to compete with LiCl and EGF, two inducers 
of the WNT pathway, both acting downstream to APC. LiCl binds directly to GSK-3β and 
inhibits the β-catenin destruction complex. In contrast, EGF activates the EGFR pathway, 
that, via AKT, promotes β-catenin detachment from the Plasma Membrane and its nuclear 
translocation. In this biological system, both LiCl and EGF induced, in a dose-response 
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manner, GFP expression in HEK293 transfected with TCF-wt GFP (Figure 24A–C). On 
the contrary, they both did not have an effect on cells transfected either with TCF-mut GFP 
or with cmv GFP (Figure 24A–C). AAE and LAE failed to inhibit activation of the WNT 
pathway induced by 15 and 30 mM LiCl. However, they both reduced WNT pathway 
activity induced by 5 and 10 mM LiCl (the results for LAE are depicted in Figure 3B). 
Moreover, at all the tested concentrations, the extract abolished the WNT stimulatory 
activity of EGF [34] (Figure 24D). These results prove that the apple extracts inhibit WNT 
pathway activation induced by LiCl and EGF and are thus suitable WNT inhibitors for 
FAP cells carrying APC mutations. 
 
  
Fig 24: .LAE inhibits the WNT pathway, acting downstream to APC. (A) The histogram shows the WNT 
pathway activity induced by LiCl (30 mM) in HEK293 cells transfected with TCF-wt GFP (green bars), 
TCF-mut GFP (grey bars) and cmv GFP (blue bars); (B) WNT pathway activity of cells treated with the 
indicated concentration of LiCl in the presence (green bars) or in the absence (grey bars) of LAE (400 mg/L); 
(C) WNT pathway activity induced by EGF (200 ng/mL) in HEK293 cells transfected with TCF-wt GFP 
(green bars), TCF-mut GFP (grey bars) and cmv GFP (blue bars); (D) WNT pathway activity of cells treated 
with the indicated concentration of EGF in the presence (green bars) or in the absence (grey bars) of LAE 
(400 mg/L). Values are reported as mean ± SEM (n = 5). *** p < 0.05, n.s. indicates non-statistical. 
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This was further proved by testing the WNT inhibitory activity that AAE and LAE exerted 
on CaCo-2 cells, a colon cancer cell line presenting mutation in the APC gene and 
commonly used as in vitro cell culture prototype for FAP cells (Figure 25B). CaCo-2 cells 
were transiently transfected with the WNT reporter GFP construct. Due to the APC 
mutation, these cells have a constitutively active WNT pathway as shown by the number of 
GFP positive cells. Upon treatment with AAE or LAE, the number of GFP expression 
decreased, indicating inhibition of the WNT pathway.  
Finally, AAE and LAE were tested in an ex vivo system of FAP cells. Human colon 
biopsies were cultured in vitro soon after their resection from FAP patients (Figure 25C). 
In unsupplemented medium, these ex-vivo samples duplicate for up to two days until their 
growth rapidly arrest. Treatment with AAE or LAE resulted in a decreased survival of the 
ex-vivo cultures. 
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Fig. 25: AAE and LAE act as WNT inhibitors in CaCo-2 cells. (A) Activity of the WNT reporter 
construct TCF-wt GFP in CaCo-2 cells cultivated for 48 h in the presence or in the absence of LAE (400 
mg/L) (representative of five experiments) (BF = Bright Field; scale bar is shown); (B) WNT pathway 
activity (green bars) and cell viability (magenta bars) of CaCo-2 cells transfected with TCF-wt GFP and 
cultivated in the absence (−) or in the presence of the indicated concentration of LAE (or of the 
corresponding dilution of DMSO). Values on the left axes indicate changes in GFP expression (a.u.). Values 
on the right axes indicate changes in cell viability expressed as percentage of untreated cells. (C) 
Proliferation rate of human colonic biopsies in culture medium supplemented with LAE or with vehicle. 
Values are expressed as mean +/- s.e.m (n=9). Anova testing. *** P<0.05. 
 
 
In an attempt to formulate a nutraceutical product, the industrial versions, IndLAE and 
IndAAE were tested. IndLAE presents a WNT inhibitory activity increased compared to 
the one got at laboratory low-scale (EC50 of WNT pathway inhibition were of 47.4 +/- 0.9 
mg/L ) (Figure 26A).  
 
 
Fig. 26. WNT inhibitory activity of IndLAE and Quercetin. A) Dose-response curves for Ind(LAE) 
modulation of WNT/β-catenin pathway. Values are reported as mean +/- s.d. (n=3). EC50 value for Ind(LAE)  
is shown under graph and is reported as mean +/- s.e.m (n=5). B) Dose-response curves for Quercetin 
modulation of WNT pathway in HEK293 cells. Values as reported as mean +/- s.d. (n=3). EC50 values for 
Quercetin is reported in Table2. 
 
HPLC-DAD analysis of the flavonoid content of the IndLAE did not reveal major change 
in the amount of poliphenols compared to AAE and LAE. However, I realized the presence 
of a discrete amount of Quercetin a molecule that was absent in the apple extracts and that 
it probably arose from the conversion of quercetin glycosides into their aglycone form. 
Tested in WNT inhibitory assay, Quercetin presented a strong inhibitory activity on the 
WNT pathway (EC50 at 110 ± 5 nM) compared to the other polyphenols alone suggesting 
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that the molecule is definitely contributing to the WNT inhibitory activity of the industrial 
extract. 
 
To achieve WNT inhibitory activity in the colon, apple polyphenolic must be 
bioaccessible, i.e. they should be extracted from the food matrix, reisist to gastrointestinal 
(GI) digestion and reach the colon-rectal section of the intestine. However, GI digestion 
may affect substantially native apple polyphenolic patterns and polyphenol concentrations 
as well as induce drastic structural changes of the food constituents. During GI digestion 
polyphenols may be further degraded (such as Anthocyanins in the small intestine), or 
hydrolyzed, deglycosylated or cleaved by esterases. To measure the bio-accessibility of the 
WNT inhibitory pool of apple polyphenol we subjected apple extracts to in vitro simulated 
digestion. Upon digestion, AAE and LAE drastically lost their WNT inhibitory activity 
(Figure 27A-B). As expected, in vitro digestion decreased the overall polyphenolic content 
of around 40-50%. This results indicate that very likely the polyphenols ingested by 
assumption of fresh fruit or fresh fruit extract will not reach the colon-rectal segment of the 
intestinal tract and strongly points towards the encapsulation of the extract in gastro-protect 
tablets as essential requirement to preserve apple extract WNT inhibitory activity.   
 
 
Fig 27: In vitro simulated gastrointestinal digestion reduced WNT inhibithory activity of AAE and 
LAE. Dose-response curves for AAE (A) and LAE (B) modulation of WNT/β-catenin pathway before 
(continuous lines) or after in vitro simulated digestion (dotted lines). Values are reported as mean +/- s.d. 
(n=3).  
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2.2.4 Discussion 
Polyphenol consumption has been related to several health beneficial effects, such as 
reduced incidence of cancer and cardiovascular diseases. The diet is the principal human 
source of polyphenolic compounds. Polyphenol-rich foods include fruits, vegetables, and 
whole grains. Here was shown that Apple Extracts from both Annurca (AAE) and 
Limoncella (LAE) possess WNT inhibitory activity. Was proven that both AAE and LAE 
inhibit the WNT pathway affecting a non-canonical branch involving PI3K and thus, 
bypassing APC for their activity, they are potentially suitable for the treatment of FAP 
patients.  
AAE and LAE WNT inhibitory activity can be partially ascribed to the polyphenolic 
fraction these apples are particularly rich in. However, none of the constituent of the 
polyphenolic fraction, tested as pure molecule, exerted strong WNT inhibitory activity, 
suggesting the importance of the entire pool of  flavonoids for the mixture to exert its 
action. This confirms what is nowadays an accepted concept of nutraceutical studies i.e. 
that phyto-complexes are always more active than pure compounds. This could be in part 
ascribed to the protection that the anti-oxidant environment of the polyphenolic mixture is 
able to exert on each of its component. This is an important aspect to underline considering 
that clinical trials are mainly focused on supplementation of single compounds, whereas 
the epidemiologic evidence supports a scenario where mixture of bioactive compounds, as 
they naturally occur in the diet, may act synergistically to be effective. 
We here show that alimentary grade large-scale manufacturing alters the flavonoid 
composition of LAE drastically increasing the WNT inhibitory activity of the extract. This 
could be ascribed to the presence of Quercetin, a potent β-catenin inhibitor absent in the 
original extract and probably originated by the conversion of Quercetin-glycosides into 
their aglycone form. Probably, it process hasn’t happened during indAAE industrial 
preparation, resulting in not liberation of Quercetin free form, so the Annurca version of 
industrial extract shows a less activity on WNT inhibitory pathway (data not shown). 
Anyway , this result should encourage researchers in testing the activity of the extract after 
large scale manufacturing because the latter drastically alters composition of the extract 
even if this event, as we have here shown, does not always have to be detrimental for the 
properties of the extract.  
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Finally was shown, that both LAE and AAE loose activity upon in vitro simulated 
gastrointestinal digestion as result of a severe loss of polyphenols. This strongly points 
towards encapsulation in gastro-resistant tablets for example enteric coatings as essential 
requirement to preserve apple extract WNT inhibitory activity in the colon-rectal section of 
the intestinal tract. 
 
 
2.2.5 Conclusion 
Apple extracts inhibit WNT pathway in colon cells carrying FAP mutations and represent a 
valid nutraceutical alternative for the treatment of this pathology. Enteric coating is 
advisable  to preserve the activity of the extracts in the colon-rectal section of the digestive 
tract. 
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Capther 3 
Potential medical device 
A potential medical device application from Annurca apple polyphenolic extracts : A  
strong inhibition of in vitro micellar cholesterol solubility by a novel Annurca apple 
based nutraceutical formulation: a NMR study. 
 
3.1 Introduction 
Previous studies have extensively demonstrated that Annurca polyphenolic extract is able 
to positively influence cholesterol metabolism. Specifically, in vitro experiments have 
proved its capacity to enhance Apolipoprotein A1 expression, the main protein constituent 
of nascent discoidal high density lipoprotein cholesterol (HDL-C), and favor low density 
lipoprotein cholesterol (LDL-C) receptor binding activity, in HepG2 cell lines (Tenore et 
al., 2013; 2014). Later, Annurca polyphenolic extract has been administered to mildly 
hypercholesterolemic healthy subjects under the form of a nutraceutical formulation, 
according to a randomised trial which has confirmed the previous in vitro results in terms 
of increase in plasma HDL-C and decrease in LDL-C levels (Tenore et al., 2017). These 
studies would indicate oligomeric procyanidins, mainly the dimeric procyanidin B2, as the 
major responsible for such effects on both in vitro and clinical HDL-C and LDL-C 
parameters. Nevertheless, the molecular mechanisms underlying these effects are still 
scarcely known. 
It has been recently reported that green tea catechins are the most effective polyphenolic 
compounds in inhibiting the micellar cholesterol solubility in the small intestine. This 
effect may be the cause of the increased fecal excretion of cholesterol observed in 
experimental animals and hypocholesterolemic activity in experimental animals and 
humans (Kobayashi et al.,2005; Kajimoto et al., 2003; Kajimoto et al 2006). Ogawa et al. 
2016 have tried to clarify this mechanism, by performing a nuclear magnetic resonance 
(NMR) study to investigate the interaction between tea catechins and cholesterol micelles 
(Ogawa et al., 2016). The data indicated the ability of epigallocatechin gallate (EGCG) to 
lower the solubility of phosphatidylcholine (PC) and cholesterol in micellar solutions due 
to their elimination from the micelles by interaction between taurocholic acids and EGCG.  
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Considering that oligomeric procyanidins occurring in apples consist of catechin 
monomeric units, it can be hypothesized that the lower molecular weight compounds 
(dimers, trimers, …) may have a similar mechanism of action to that of monomeric 
catechins as regards their effects on micellar cholesterol solubility. To clarify this aspect, 
the aim of the present work will be to evaluate the in vitro effect of Annurca apple 
polyphenolic extract on micellar cholesterol solubility in a model reproducing the duodenal 
environment. Specifically, a main goal will be to elucidate the molecular mechanism of 
action by performing a NMR study for the interaction between Annurca polyphenols and 
bile acids. The attention will be focused on the effects of an industrial nutraceutical 
product formulated by using Annurca water extract microencapsulated with maltodextrins 
(AMD). 
 
3.2 Materials and methods 
3.2.1 Reagents and standards 
All chemicals and reagents used were either analytical-reagent or HPLC grade. The water 
was treated in a Milli-Q water purification system (Millipore, Bedford, MA) before use. 
The standards used for the identification and quantification of phenolic acids and 
flavonoids were: chlorogenic acid, [+]-catechin, [-]-epicatechin, isorhamnetin, myricetin, 
phloretin, phloridzin (phloretin-2-O-glucoside), procyanidin B2, quercetin, quercitrin 
(quercetin-3-O-rhamnoside), rutin (quercetin-3-O-rutinoside), isoquercitrin (quercetin-3-O-
glucoside), hyperin (quercetin-3-O-galactoside) and cyanidin-3-O-galactoside chloride 
(Sigma Chemical Co., St. Louis, MO). Acetonitrile and methyl alcohol were of HPLC 
grade (Carlo Erba, Milano, Italy). Sodium taurocholate, phosphatidylcholine, cholesterol, 
NaCl, and sodium phosphate, were purchased from Sigma Chemical Co. 
 
3.2.2 Fruit collection and sample preparation 
Annurca (M. pumila Miller cv Annurca) apple fruits were collected in Valle di Maddaloni 
(Caserta, Italy) in October 2016 when fruits had just be harvested (green peel). Fruits were 
reddened, following the typical treatment (Lo Scalzo et al., 2001) for about 30 days, and 
then analysed. Other two apple varieties analysed in this study, Pink Lady (PL) (M. pumila 
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Miller cv Pink Lady), and Golden Delicious (GD) (M. pumila Miller cv Golden Delicious), 
were acquired in a local supermarket. Lyophilised apples (10 g) were treated with 100 mL 
of 80% methanol (0.5% formic acid) for 24 h at 4 °C to extract phenolic compounds. After 
centrifugation, the supernatant was slowly filtered through an Amberlite XAD-2 column 
packed as follows: resin (10 g; pore size 9 nm; particle size 0.3-1.2 mm; Supelco, 
Bellefonte, PA, USA) was soaked in methanol, stirred for 10 min and then packed into a 
glass column (10 x 2 cm). The column was washed with 100 mL of acidified water (pH 2) 
and 50 mL of deionised water for sugar and other polar compound removal. The adsorbed 
phenolic compounds were extracted from the resin by elution with 100 mL of methanol, 
which was evaporated by flushing with nitrogen. 
 
3.2.3 Industrial preparation of Annurca nutraceutical product (AMD) 
AMD consisted of Annurca apple extract microencapsulated with maltodextrins. Large-
scale production of AMS was accomplished by MB-Med Company (Turin, Italy). Apples 
were extracted with water at 35 °C. After centrifugation, the extract was spray-dried in 
combination with maltodextrins, obtaining a fine powder with a maltodextrins/extract ratio 
4:1. 
 
3.2.4 HPLC-DAD/ESI-MS analysis  
Extracts from the three different apple varieties and AMD were solubilized with 1% formic 
acid. Analyses were run on a Jasco Extrema LC-4000 system (Jasco Inc., Easton, MD) 
provided with photodiode array detector (DAD). The column selected was a Kinetex
®
 C18 
column (250 mm × 4.6 mm, 5 μm; Phenomenex, Torrance, CA). The analyses were 
performed at a flow rate of 1 mL/min, with solvent A (2% acetic acid) and solvent B (0.5% 
acetic acid in acetonitrile and water 50:50, v/v). After a 5 min hold at 10% solvent B, 
elution was performed according to the following conditions: from 10% (B) to 55% (B) in 
50 min and to 95% (B) in 10 min, followed by 5 min of maintenance. Flavonols, 
procyanidins, dihydrochalcones, flavanols and hydroxycinnamic acids were monitored at 
280 nm and anthocyanins at 520 nm. For quantitative analysis, standard curves for each 
polyphenol standard were prepared over a concentration range of 0.1-1.0 μg/μL with six 
different concentration levels and duplicate injections at each level. The identity of 
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polyphenols was confirmed by LC-ESI/MS experiments and data were compared to those 
of commercial standards. The same chromatographic apparatus and conditions (HPLC 
system, gradient elution, column, temperature) was coupled to an Advion Expression mass 
spectrometer (Advion Inc., Ithaca, NY) equipped with an Electrospray (ESI) source. Mass 
spectra were recorded from m/z = 50 to 1200, both in negative and in positive ionization 
mode. The capillary voltage was set at − 28 V, the spray voltage was at 3 kV and the tube 
lens offset was at − 10 V in negative ion mode, while the capillary voltage was set at 34 V, 
the spray voltage was at 3.5 kV and the tube lens offset was at 55 V in positive ion mode. 
The capillary temperature was 275 °C. Data were acquired in full scan and SIM modes.  
 
3.2.5 In vitro effects of apple polyphenolic extracts on cholesterol micellar solubility 
The effects of purified apple polyphenolic extracts and AMD on the micellar solubility of 
cholesterol were examined as described by previous authors (Ikeda et al; 2003). A bile salt 
micellar solution containing 6.6 mmol/L sodium taurocholate, 0.6 mmol/L PC, 0.5 mmol/L 
cholesterol, 132 mmol/L NaCl, and 15 mmol/L sodium phosphate (pH 6.8) was prepared 
by sonication and stored at 37 °C for at least 24 h. Aliquots (100 μL) of apple polyphenolic 
extract solutions and AMS (100 μg/mL) in deionized water stored at 37 °C were added to 
the 3 mL micellar solutions. The mixture was incubated for 1 h at 37 °C. The solution 
reveals an evident opalescence due to cholesterol precipitation (Fig. 28). The supernatant 
was passed through a 0.2 μm syringe filter (25 mm; GDD/X; Whatman Inc., Piscataway, 
NJ, USA), and the cholesterol content originating from the phospholipids was analysed by 
gas chromatography using an SPB-1 column (Supelco, Bellefonte, PA, USA) and a DB-
WAX column (Agilent Technologies, Santa Clara, CA, USA), respectively. 
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Fig. 28: (A) Micellar solution of cholesterol; (B) Precipitation of cholesterol after addition of apple 
polyphenolic extract solutions. 
 
3.2.6 Statistics 
All of the experimental data were expressed as mean ± standard deviation (SD) of at least 
five replications. Statistical analysis of data was carried out  by the Student’s t test or two-
way ANOVA followed by the Tukey–Kramer multiple comparison test to evaluate 
significant differences between a pair of means. The level of significance (α-value) was 
95% in all cases (P < 0.05). The degree of linear relationship between two variables was 
measured using the Pearson product moment 
 
 
3.3 Results and Discussion 
3.3.1 Effects of apple extracts and AMD on in vitro cholesterol micellar solubility 
The effects of the three apple extracts and AMD on in vitro micellar solubility of 
cholesterol was tested. As shown in Figure 29, Annurca was able of the highest influence 
on cholesterol solubility among the apple samples. 
 
 
A B 
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Fig. 29: Effect of apple sample extracts and Annurca nutraceutical formulation (AMD) on micellar 
solubility of cholesterol in vitro. Ann: Annurca; GD: Golden Delicious; PL: Pink Lady.Data are means ± SE 
of triplicate experiments. Results were significantly different at a level of P = 0.001. abcdMean values with 
different superscript letters are significantly different by the Tukey-Kramer multiple comparison test. 
 
Previous authors have demonstrated that the addition of green tea catechins with a galloyl 
moiety to a bile salt micellar solution precipitated cholesterol and decreased the micellar 
solubility of cholesterol in a dose-dependent manner (Ikeda et al; 1992). In contrast, green 
tea catechins without a galloyl moiety did not precipitated cholesterol. When purified 
EGCG was added to the bile salt micellar solution, the amount of EGCG precipitated from 
the micellar solution was highly positively correlated with the amount of cholesterol 
precipitated. These results strongly suggested that EGCG eliminated the cholesterol from 
the bile salt micelles and co-precipitated with cholesterol. Later, Kobayashi et al. (2014) 
showed for the first time that green tea catechins with a galloyl moiety, but not those 
without a galloyl moiety, eliminated not only cholesterol but also PC from bile salt 
micelles (Kobayashi et al., 2014). When bile salt micelles contained a phospholipid other 
than PC, neither cholesterol nor the phospholipid was eliminated by the addition of EGCG. 
These observations suggest that green tea catechins with a galloyl moiety interact with PC 
and the binding of EGCG to PC decreases PC solubility. The same authors have confirmed 
these results by performing NMR studies on the same in vitro models of cholesterol 
vesicles and green tea catechins. An intermolecular nuclear Overhauser effect (NOE) was 
observed between PC and EGCG in bile salt micelles with EGCG added, but not between 
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cholesterol and EGCG. These observations strongly suggested that EGCG decreases the 
micellar solubility of cholesterol via specific interaction with PC. Apple procyanidins are 
oligomeric compounds consisting of catechin monomeric units. Specifically, dimeric 
procyanidins are the most structurally similar to the green tea catechins with a galloyl 
moiety (Figure 30).  
 
 
 
 
 
                     
   
Fig. 30:Chemical structures of apple dimeric procyanidins and green tea galloylated catechins. 
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Therefore, it could be hypothesized that these dimers may play a major role as regards our 
observed effects of apple extract samples on in vitro cholesterol micellar solubility (Figure 
28).  This effect was related to different quantity of dimeric procyanidins in the extracts 
tested. The results of LCMS analysis are reported in the following table  
 
Table 11. Polyphenolic composition of apple extracts and nutraceutical formulation (AMS) 
determined by HPLC-MS 
 
 Annurca Pink Lady Golden 
Delicious 
AMS 
     
Chlorogenic acid 106.2 ± 
10.2 
100.4 ± 8.7 104.2 ± 7.2 0.04 ± 
0.001 
p-Coumaroylquinic acid ND ND ND ND 
[+ ]-Catechin 62.4 ± 4.7 59.7 ± 4.2 57.2 ± 3.7 0.3 ± 0.02 
[− ]-Epicatechin 68.1 ± 5.2 60.3 ± 4.6 59.4 ± 4.0 0.3 ± 0.02 
Procyanidin B1 6.52 ± 0.5 4.62 ± 0.7 5.71 ± 0.9 0.2 ± 0.01 
Procyanidin trimer 12.6 ± 1.9 53.8 ± 3.9 10.1 ± 1.7 0.3 ± 0.01 
Procyanidin B2 16.0 ± 1.8 6.01 ± 0.8 10.2 ± 1.7 0.04 ± 
0.001 
Procyanidin trimer (isomer) 21.3 ± 2.1 63.7 ± 5.1 16.1 ± 1.8 0.2 ± 0.02 
Cyanidin-3-O-galactoside 0.41 ± 
0.04 
ND ND ND 
Rutin (Quercetin-3-O-rutinoside) 42.7 ± 3.5 38.4 ± 2.8 36.1 ± 2.2 0.06 ± 
0.002 
Hyperin (Quercetin-3-O-galactoside) 109.1 ± 
11.3 
100.4 ± 9.2 98.1 ± 8.1 ND 
Isoquercitrin (Quercetin-3-O-glucoside) 72.6 ± 4.3 69.5 ± 4.4 67.1 ± 3.5 ND 
Reynoutrin (Quercetin-3-O-xyloside) 76.8 ± 3.8 70.0 ± 4.5 68.4 ± 3.4 ND 
Guajaverin (Quercetin 3-O-
arabinopyranoside) 
72.5 ± 3.7 67.2 ± 3.8 64.2 ± 2.7 ND 
Avicularin (Quercetin 3-O-
arabinofuranoside) 
76.6 ± 4.1 70.2 ± 4.1 68.2 ± 3.6 ND 
Quercetin-O-pentoside 43.8 ± 2.7 42.6 ± 3.2 40.0 ± 3.2 ND 
Quercitrin (Quercetin-3-O-rhamnoside) 72.9 ± 3.6 65.6 ± 4.0 63.3 ± 4.0 ND 
Phloretin-2-O-xyloglucoside 64.4 ± 2.5 62.2 ± 3.8 60.3 ± 3.8 0.06 ± 
0.003 
Phloridzin (phloretin-2-O-glucoside) 65.3 ± 3.5 61.5 ± 3.6 59.1 ± 3.6 0.06 ± 
0.002 
Results were expressed as μg/mg DW ± SD (n = 3).  
Results were significantly different at a level of P = 0.001. 
ND: not detected. 
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These results showed that the Annurca polyphenolic extract was richer in dimeric 
procyanidins than other extract analysed, thus probably these compouds are responsible of 
this in vitro effect. This concept could be confirmed by a significant statistical correlation 
(R
2
 = 0.9511) between dimeric procyanidin content of apple extracts and the observed 
cholesterol precipitation (Figure 31).  
 
Fig. 31: Statistical correlation between dimeric procyanidin content of apple extracts and effect of 
apple extract solutions on in vitro solubility of micellar cholesterol. 
 
 
Very interestingly, AMD exerted the strongest effects among all of the samples tested, 
although its much lower polyphenolic content than the other samples (Figure 29). A 
possible explanation could be found in its same technological formulation. In fact, AMD 
consists of Annurca polyphenolic extract microencapsulated in maltodextrins. Such vehicle 
may facilitate the water dispersion of polyphenols which are well known to be 
characterised by a quite low solubility in an aqueous medium. It could be hypothesized that 
the three apple extracts, although much richer in polyphenolic compounds, allow a very 
low water accessibility of their constituents to the cholesterol vesicles, while the 
polyphenolic aliquot provided by AMD could be much more effective than that of the 
other samples. However, this aspect needs to be further clarified.  
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3.3.2 NMR study of interaction of apple extracts and AMD with bile acid micelles 
Figure 32 shows the 
1
H NMR spectrum of the bile acid micelles alone, and after the 
addition of equal amounts (100 μg/mL) of three apple extracts and AMD. Interaction of 
both apple extracts and AMD with the bile salt micelles resulted in a shift of a few signals 
of the micelles, among those the most influenced was the signal of the trimethylammonium 
group in phosphatidylcholine (Figure 32). 
 
 
Fig. 32: Expanded region of the 1H NMR spectrum of bile salt micelle (blue), after the addition of 
pink lady apple extracts (black), after the addition of golden apple extracts (green), after the 
addition of Annurca apple extracts (red), after the addition of AMD (violet). 
 
The shift was more intense in case of Annurca (-3 ppb) than GD extract (-2 ppb), while PL 
extract had no effect on micelle proton signals. This result indicates that Annurca extracts 
have a higher content of metabolites able to interact with the bile salt micelle compared to 
the other two apple species. Interestingly, AMD provided the highest signal shift, in 
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accordance with the results obtained from the in vitro cholesterol precipitation (Figure 29). 
The relatively intense upfield shift of the trimethylammonium group in 
phosphatidylcholine is in accordance with the results of Kobayashi et al. (2014) who 
reported that polyphenolic constituents of green tea, in particular epicatechin gallate and 
epigallocatechin gallate, interact with bile acid micelles through the trimethylammonium 
group in phosphatidylcholine (Kobayashi et al., 2014).  
The addition of apple extracts and AMD to the micelles also caused the upfield shift of the 
same NMR signal.To identify extract components that bind the bile salt micelles, I used 
nuclear magnetic resonance saturation transfer difference (STD) spectroscopy. The method 
relies on the possibility to selectively saturate protons of macromolecular system (receptor) 
by irradiating the spectral region containing resonances of the macromolecular system 
which is also free of any smaller molecule signals. Due to effective spin diffusion 
saturation quickly propagates across the entire receptor. If the smaller molecule ligand 
binds the receptor, saturation will also spread onto the ligand. The result will be that 
intensity of the ligand signal will be attenuated. Subtraction of resulting spectrum from the 
reference spectrum without saturation yields the STD spectrum containing only signals of 
the binding ligands. STD experiment was acquired on the sample containing the Annurca 
extracts and the bile salt micelles (Figure 33) 
On-resonance irradiation frequency was set at 1 ppm where only micelle resonances are 
present. To guarantee the absence of direct irradiation on extracts signals, an appropriate 
blank experiment was also performed. As shown in Figure 33, only a few signals were 
present in the STD spectrum among those observable in the original 1H NMR spectrum of 
the Annurca extracts in the presence of bile salt micelles. Among the others, signals 
assignable to chlorogenic acid and its analogues (6.2, 7.0, and 7.4 ppm) were not visible in 
the STD spectrum indicating that these compounds do not interact with the micelle. In 
contrast, signals around 5.9 and between 7.0 and 6.5 ppm are clearly visible in the STD 
spectrum. Considering the possible chemical constituents of the Annurca extracts these 
signals are fully compatible with (epi)catechin or procyanidins. For comparison purposes, 
also the proton NMR spectrum of Procyanidin B2 is reported. 
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Fig. 33: Expanded region of the 1H NMR spectrum of annurca extracts in the presence of bile salt 
micelle (a) and the corresponding STD spectrum (c). Expanded region of the 
1
H NMR spectrum of 
AMD in the presence of bile salt micelle (b). The star indicates sample impurity. 
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3.4 Conclusions 
In vitro experimental results have demonstrated that apple polyphenolic extracts are able to 
decrease the cholesterol solubility in a model of duodenal bile micelle solution. This effect 
seems to be statistically correlated with the dimeric procyanidin content of the apple 
extracts, so that Annurca sample, being characterised by the highest concentration of these 
polyphenolic compounds, is able to exert the strongest effect on the micellar cholesterol 
solubility among the other apple extract samples. The 
1
H NMR experiments have indicated 
that PC in the bile micelles could be the preferential target of the apple polyphenolic 
extracts, considering the evident shifts of the PC signals in the NMR spectrum. STD 
spectroscopy have allowed to hypothesise that the polyphenols responsible for these shifts 
are mainly (epi)catechin or dimeric procyanidins, confirming what already reported in the 
literature for the galloylated green tea catechins, compounds structurally similar to dimeric 
procyanidins.  
The same in vitro and NMR experiments have indicated for AMD much higher effects than 
the apple extract samples, in terms of both cholesterol precipitation and PC signal shifts in 
the NMR spectrum. Although its lower polyphenolic content at the same concentration in 
the solutions tested, AMD could be expected to better vehicle polyphenols to the micelle 
targets, thanks to its polar microencapsulated formulation. This product may be regarded as 
a powerful tool to decrease cholesterol solubility at the duodenal tract and, thus, its 
intestinal bioavailability. Therefore, the present work proposes AMD as an effective device 
to lower cholesterol absorption in mildly hypercholesterolemic healthy subjects.  
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